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CHAPTER 1: GENERAL INTRODUCTION 
Statement of the Problem 
Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis) is an 
intracellular pathogen of macrophages (5) in ruminant species and is the cause of 
paratuberculosis (Johne's disease). M. paratuberculosis is transmitted from infected cattle to 
calves through fecal contamination within the environment, in utero, or through ingestion of 
infected colostrum or milk (26, 103). In some animals, infection apparently does not become 
established (26) whereas other animals become persistently infected. The disease can be 
divided into three phases (70). During the initial phase, the animal is infected but not 
shedding organisms in the feces. The persistently infected animal enters the subclinical 
phase, in which there is active lesion development with shedding of less than 10 colony-
forming units (CPU) of M prartuberculosis per gram of feces (70). Following a 3-5 year 
incubation, animals gradually enter the clinical phase, where shedding of greater than 100 
CPU of M. paratuberculosis per gram of feces is observed. In subclinical paratuberculosis, 
production losses are noted (86), whereas in clinical disease there is cachexia, profuse 
diarrhea, and hypoproteinemia (136). 
M. paratuberculosis preferentially infects the intestine, where it elicits granulomatous 
inflammation. Grossly, the lesions of paratuberculosis present as variable degrees of 
cerebreform mucosal thickening of the distal small intestine (15). Histologically, there are 
gradations in the severity of the granulomatous response. In cattle with mild lesions, there 
are individual Langhans-type giant cells within the lamina propria of the ileum and within the 
paracortices of associated lymph nodes; acid-fast bacilli (AFB) are rare (15). With more 
advanced lesions, there are small groups of macrophages and Langhans-type giant cells 
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within the lamina propria, within the submucosa, and in the subcapsular sinuses and 
paracortices of the regional lymph nodes; AFB are more frequent than in the mild lesions. In 
the most severe lesions, there is transmural accumulation of macrophages and giant cells 
within the small intestine as well as within distended and inflamed lymphatic vessels. 
Sinuses of mesenteric lymph nodes are filled with macrophages and giant cells; these cells 
extend into the paracortices. AFB are frequent in these severe lesions. In all forms of 
paratuberculosis, necrosis and caseation, as observed in tuberculous granulomas are absent 
(15). 
Protective immunity to mycobacteria requires a T helper type 1 (Thl) lymphocyte 
response. Thl cells are CD4+ T cells which produce cytokines including interferon (IFN)-y 
and interleukin (IL)-2 (80) which regulate the cell-mediated immune response. During this 
response, antigen-specific production of IFN-y activates infected macrophages to kill 
intracellular mycobacteria (113). In contrast to Thl cells, Th2 cells produce IL-4, IL-5, and 
IL-10 (68) and are involved in humoral immunity. Antibody-mediated responses are not 
protective in mycobacterial infection (111), and persons with defects in humoral immunity 
do not have increased susceptibility to M. tuberculosis infection (113). 
Mycobacterium leprae infection in humans provides a model for the potential role of 
Th subsets in defining lesion development in mycobacterial infections. Lesions of leprosy 
form a continuum, with tuberculoid (resistant) lesions composed of lymphocytes and 
macrophages in nodular granulomas, which are self-healing and contain the mycobacterial 
agent, on the one end of the spectrum, and the lepromatous (susceptible) form consisting of 
diffuse sheets of macrophages, on the other end (139). Within the lesions of the tuberculoid 
form, mRNA for LFN-y, IL-2, IL-1(3, and tumor necrosis factor (TNF)-a were detected, 
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whereas in the lepromatous form, mRNA for IL-4, IL-5, and IL-10 were produced (139). 
The data suggest that cytokine patterns produced by T cells are important in the formation of 
the spectrum of lesions and degree of mycobacterial killing in M. leprae infection (139). In 
sheep, the intestinal lesions of M. paratuberculosis infection can be similarly divided into 
tuberculoid and lepromatous forms. In the tuberculoid form, bacterial numbers within 
lesions are usually low, and the cellular infiltrate is composed of macrophage accumulations 
surrounded by large numbers of lymphocytes (18). In the more common lepromatous form, 
mycobacteria are present in high numbers and the intestinal lamina propria is expanded by 
sheets of epithelioid macrophages (18). The Thl versus Th2 dichotomy has not been as well 
established in paratuberculosis lesions, but sheep with the tuberculoid form had stronger 
antigen-specific lymphocyte proliferative responses in peripheral blood, mesenteric lymph 
node, and ileal laminai propria than those with the lepromatous form (18), and lymphocytes 
from animals with the tuberculoid form produced more antigen-specific EFN-y and IL-2 than 
those with the lepromatous form (17). 
The immune response in M. paratuberculosis-infected cattle has a well-described 
transition as animals move from the subclinical to the clinical phase. During the subclinical 
phase, infected animals have a strong Thl-type cell-mediated immune response, as evidenced 
by delayed-type hypersensitivity (DTH) responses, proliferative responses by lymphocytes 
stimulated with M. paratuberculosis antigen, and antigen-specific production of IFN-y and 
TNF-a.by lymphocyte cultures (109, 111). Following experimental oral infection, calves 
developed an antigen-specific CD4+ T cell proliferative response in the periphery 6 months 
after infection (71). After experimental intratonsillar infection, antigen-specific CD4+ T cell 
proliferation was detected in the peripheral blood of cattle 286 days post-inoculation, with 
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antigen-specific production of IFN-y by CD4+ T cells at 313 days post-inoculation (132). 
During progression from the subclinical to clinical phases, however, cell-mediated immunity 
begins to wane. Compared to subclinical animals, animals with clinical paratuberculosis had 
significantly decreased IFN-y mRNA expression in the ileum and cecal lymph node (116). 
Stimulated peripheral blood mononuclear cells (PBMC) from animals with clinical disease 
produced significantly less IFN-y, TNF-a, and IL-2 than subclinical animals (110). During 
the clinical phase, there is a shift towards a strong humoral immune response (111). 
Compared to control cows or cows with subclinical paratuberculosis, animals with clinical 
disease had higher percentages of circulating B cells (133). Antibody to M. paratuberculosis 
is not protective (111), and the large amounts of circulating anti-M. paratuberculosis 
antibody observed in clinical animals are used in current diagnostic tests to detect cattle in 
the terminal phases of the disease. 
The lesions of Johne's disease are difficult to induce experimentally 
The lesions of paratuberculosis continue to be difficult to reproduce experimentally. 
In one study, only 8 of 26 experimentally-inoculated calves had lesions of Johne's disease 
detectable histologically in the intestine and mesenteric lymph nodes thirteen months after 
oral administration of M. paratuberculosis, although the organism could be grown on culture 
of intestinal mucosal scrapings from 25 of 26 calves (47). Several models of Johne's disease 
in mice have been developed to study the granulomatous inflammation caused by M. 
paratuberculosis (24, 119, 122, 126). Although models of Mycobacterium tuberculosis 
infection in mice appear to mimic the pathologic and immunologic course of disease in 
humans (76), the classic enteric lesions associated with paratuberculosis in ruminants are 
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lacking in M. paratuberculosis-infected mice, and it has been suggested that the usefulness of 
murine models may instead lie in the evaluation of potential antimycobacterial 
chemotherapies (24). 
The role of yô T cells during infection with M. paratuberculosis is not known 
Although much is known regarding the cellular response to mycobacteria, the 
functional role of yô T cells in controlling mycobacterial infection is presently unclear. In 
humans and primates, yb T cells proliferate in response to protein (13,14) and non-protein 
(79, 95,131) antigens of mycobacteria m vitro. Human yb T cells produce IFN-y when 
stimulated with mycobacterial antigens (46) and accumulate in mycobacterial lesions in vivo 
(75). It has been suggested that yb T cells may provide a first line of defense before the more 
efficient IFN-y-producing a|3 T cells are recruited to the lesion sites (2), and the IFN-y 
produced by yb T cells in concert with IL-12 produced by infected macrophages may help 
ensure a Thl bias to the developing immune response (93). In M. 6ov/s-infected cattle, yb T 
cells proliferate (94) and produce IFN-y (128) in response to mycobacterial antigenic 
stimulation. Given this capacity to produce IFN-y in response to mycobacterial infection, yô 
T cells may play a role in the activation of infected macrophages to increase mycobacterial 
killing. Others have reported yô T cell-mediated increases in macrophage TNF-a production 
during exposure to lipopolysaccharide (LPS) (81) and yô T cell regulation of nitric oxide 
production in experimental candidiasis (63), suggesting a role in activation of macrophages 
in other experimental systems. To date, yb T cell-mediated macrophage activation has not 
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been demonstrated in mycobacterial infection, and their role in M. paratuberculosis infection 
has not been fully characterized. 
Specific Aims 
It was our goal to develop an experimental system for inducing the granulomatous 
inflammation of paratuberculosis and a T cell response from the lymph node draining the site 
of infection, and to use this system to ask questions regarding T cell behavior during 
paratuberculosis. We wanted to determine if the behavior of lymphocytes in the lymph node 
draining the site of infection was different from that of lymphocytes derived from the 
peripheral blood and the spleen. Using this experimental system, we then sought to 
determine if yô T cells derived from the lymph node draining the site of infection could be 
primed to activate M. paratuberculosis-infected macrophages to upregulate bactericidal 
responses. We compared the function of yô T cells with that of antigen-primed CD4+ T cells, 
which activate macrophages in other experimental systems, as a control. 
Dissertation Organization 
This work has been organized in the alternative dissertation format. This dissertation 
is composed of a general introduction and literature review (chapter 1), three manuscripts 
(chapters 2-4) which have been prepared for submission to three different scientific journals, 
and a chapter detailing general conclusions (chapter 5). References are cited at the end of 
each chapter. 
LITERATURE REVIEW 
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yô T cells 
Introduction 
There are two distinct lineages of CD3+ lymphocytes which bear a non-covalently-
linked heterodimeric T cell receptor (TCR); CD3+ cells containing a and (3 antigen receptor 
chains, and T cells with a yb TCR. Whereas a|3 T cells are predominantly localized to the 
blood and lymphoid tissues, yb T cells are prominent at epithelial surfaces such as the 
intestine, tongue, esophagus, trachea, bladder, skin, (52) and uterus (63) and may play a role 
in immunologic surveillance for infection or transformation of epithelia (59). Studies to date 
have documented a role for yb T cells in cellular immunity to intracellullar pathogens such as 
Mycobacterium tuberculosis (12, 61), Leishmania major (96), and Listeria monocytogenes 
(53), as well as in wound repair (22, 58), and autoimmunity (90). 
yb T cell biology has been well studied in humans, mice, and ruminants. There are 
marked differences between species regarding the presence or absence of certain yb T cell 
subsets, numbers of circulating yb T cells, and responsiveness of yb T cells to particular 
pathogens. While in humans the most prevalent yb T cell subset is that which expresses the 
Vy9Vô2 heterodimer (66), there is no such subset in mice and ruminants. In humans and 
mice, approximately 1-10% of circulating T cells bear the yb TCR (64). In neonatal 
ruminants, up to 60% of circulating CD3+ cells are yb T cells; this percentage declines to 
approximately 30% of CD3+ cells at 1 year of age and to 5-10% of PBMC at 5-8 years of age 
(52). The majority of circulating yb T cells in humans respond to antigens derived from 
mycobacteria; similar mycobacterial reactivity by the majority of yb T cells in circulation in 
mice and ruminants has not been described. For these reasons, it is often difficult to 
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extrapolate specific findings regarding yô T cell behavior across species lines. Regardless of 
these species differences, experiments on yô T cells over the last 20 years have revealed 
some common themes across species, and there are substantial generalizations which can be 
made regarding the function of yô T cells during infectious diseases and inflammatory 
processes. 
The genetic structure of the yô T cell receptor 
The genetic arrangement of the human yô TCR has been extensively studied. The y 
and Ô genes have variable (V), joining (J), and constant (C) regions, similar to the TCR a and 
P genes; Ô and |3 genes additionally contain diversity (D) segments whereas a and y genes do 
not (57,60, 118). Compared to a|3 TCR genes there is limited germline diversity of the yô 
TCR (64). There are fewer V chain segments among the y and ô genes compared to those of 
the a(3 TCR. The ô chain genes are situated entirely within the «-chain locus; the number of 
ô segments is unknown, but at least four have been characterized. There are three Dô 
segments, three JÔ segments, and one Cô segment between the Va and Ja gene segments. 
The y chain locus contains 12 V segments, a Cyl segment with three J segments, and a Cy2 
gene with two J segments (60). 
Compared to the human sequence data, less is known about the genetic structure of 
the bovine yô TCR. In cattle, nine y chain and three ô chain cDNA clones have been isolated 
(118). Nine Vy segments have been characterized and designated Vyl, Vy2, Vy2.1, Vy2.2, 
Vy2.3, Vy3.1, Vy3.2, Vy5, and Vy7 (43, 57). Four different Cy segments (57) and a single 
Cô segment have been found in the bovine genome (118). Two Vô and three Jô segments 
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were isolated from three TCR ô cDNA clones (57,118). Cattle preferentially use Vy5 with 
Cyl or Cy2 and Vôl (57). The reasons for this preferential usage are unclear. 
yô T cell activation and proliferation 
Factors regulating the activation and proliferation of yô T cells are incompletely 
understood. As with a|3 T cells, proliferation of yô T cells is IL-2 dependent (95). Using 
expression of the IL-2 receptor (IL-2R) a-chain as a marker of T cell activation, it has been 
shown that yô T cells cultured in the presence of the T cell mitogen concanavalin A (con A) 
become activated, whether in the presence or absence of professional antigen-presenting cells 
(APC) (50). While yô T cells from afferent lymph, which contains APC, proliferated in 
response to con A stimulation, yô T cells from efferent lymph, which lacks APC, did not 
proliferate to con A unless exogenous IL-2 was also added, suggesting that yô T cells do not 
produce sufficient IL-2 to induce proliferation (50). Addition of APC to yô T cells from 
efferent lymph restored their ability to proliferate in response to con A, suggesting that yô T 
cells require costimulation by APC to sufficiently upregulate production of IL-2 to stimulate 
proliferation (50). 
Costimulatory pathways of activation and proliferation of yô T cells are poorly 
understood, yô T cells express CD28 (50, 108, 121) and CTLA-4 (50), co-receptors for B7-1 
(CD80) and B7-2 (CD86), respectively. In mice, costimulation through CD28 is required for 
autocrine production of IL-2 by yô T cells (108). In sheep, yô T cells express low levels of 
CD28 and CTLA-4 in CD4+ and CD8+ T cell-depleted cultures, and expression markedly 
increases in the presence of CD4+ and CD8+ T cells (50). Proliferation of sheep yô T cells 
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was still marked in CD4+ and CD8+ T cell-depleted cultures, (i.e., those with little CD28 and 
CTLA-4 expression), suggesting that ruminant yb T cells may utilize alternative 
costimulatory pathways (50). One such alternative source of costimulation might include the 
NKG2D-MICA pathway (35). NKG2D is a C-type lectin-like cell surface molecule 
expressed by human yb T cells which interacts with the MHC class-I related chains (MIC) A 
and B on the surface of stressed or infected dendritic cells and epithelial cells (35). In the 
presence of M tuberculosis protein and nonprotein antigens, MICA+ target cells were lysed 
by Vy9Yô2 T cells; antibodies against NKG2D or against MICA blocked specific lysis (35). 
MICA-transfected cells were not lysed in the absence of these antigen (35). Thus, NKG2D-
MICA interactions may provide a second signal to that provided through the yb TCR for 
antigen-specific yb T cell effector function (35). 
Regulation of bovine yb T cell proliferation by monocytes has been extensively 
studied (84, 85, 97). Normal bovine monocytes inhibit yb T cell proliferation through 
secretion of an inhibitory protein (84). The factor did not induce yb T cell death, and yb T 
cells were still responsive to con A stimulation. Monocytes did not induce anergy, as 
addition of IL-2 to cultures did not overcome the suppression. Gamma-irradiated monocytes, 
in contrast, do not inhibit, but rather stimulate proliferation of yb T cells (85). Similarly, 
paraformaldehyde-fixed monocytes stimulate yb T cell proliferation, suggesting that the 
stimulatory ligand is membrane associated. The membrane-associated molecule was 
sensitive to proteinase digestion (85), and stimulation through this molecule required 
interaction with the yb TCR (97). 
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These experiments suggest a model of monocyte-yô T cell interaction in cattle such 
that constitutive expression of the soluble inhibitory factor could prevent proliferation of yô T 
cells by the membrane ligand (84). When protein synthesis by monocytes decreases, due to 
factors such as intracellular infection, irradiation, or other injurious stimuli, the inhibitory 
function is lost and yô T cells proliferate in response to stimulation by the constitutively-
expressed ligand (85). Proliferation and cytokine production by yô T cells in response to 
damaged monocytes, independent of antigen presentation, could provide an earlier response 
to injury or intracellular infection than that provided by a(3 T cells (85). Interestingly, 
expression of the constitutively-expressed monocyte membrane ligand is decreased with 
IFN-y treatment of monocytes, suggesting a feedback mechanism to dampen yô T cell 
responses when sufficient macrophage-activating cytokines are present (97). 
Thl polarization and cytokine production 
Although yô T cells can be stimulated to produce either Thl- or Th2-type cytokines 
(42), murine and human yô T cells default to a Thl phenotype even in the presence ofIL-4 
and anti-IFN-y (140). Human yô T cells stimulated with killed M. tuberculosis, killed group 
A streptococci, or killed Listeria monocytogenes produced IFN-y and IL-2, but not IL-4, 
suggesting a strong Thl bias in the response by yô T cells to bacteria (45). Human yô T cells 
stimulated with non-peptide antigens from M. tuberculosis produce IFN-y, but not IL-4, and 
IFN-y production is markedly enhanced with the addition of exogenous IL-12 (46). Culture 
of human yô T cells in the presence of non-peptide mycobacterial antigens and IL-4 did not 
enhance their ability to produce IL-4, as measured by intracellular cytokine staining (46). 
In contrast to a(3 T cells, yô T cells can produce IFN-y when polarized to a Th2 
phenotype with exogenous IL-4 and anti-IFN-y (140). When cultured with a combination of 
IL-12 and IL-4, murine yô T cells default to a Thl phenotype, unlike «p T cells, in which the 
effects of IL-4 are dominant (140). yô T cells express the IL-12 receptor ^ chain when 
polarized with either IL-12 or IL-4, even in IFN-y -/- mice (140). IL-4 induces the 
expression of the Th2 transcription factor GATA-3 by yô T cells; however, expression of 
GATA-3 does not block the expression of the IL-12 receptor (3: chain (140). 
yô T cells cultured in the presence of IL-12 produced IFN-y without accompanying 
proliferation (2). The amount of IFN-y produced by yô T cells was less than the amount 
produced by a|3 T cells in the same cultures, suggesting that yô T cells may be a first line of 
cellular defense which produces IFN-y until the more efficient a(3 T cells are recruited to the 
site (2). Production of IFN-y by yô T cells and production of IL-12 by infected macrophages 
may help to ensure a Thl bias to the recruited a|3 T cells (reviewed in (93)). 
Antigen presentation and lack of MHC restriction 
Various studies have given mixed results as to the MHC restriction of yô T cells, with 
early studies suggesting traditional MHC restriction of yô T cells (51), but the majority of 
more recent studies suggest that antigen recognition by yô T cells in various species is 
independent of MHC class I or class II (65). Most yô T cells in humans and mice do not 
express CD4 or CDS, the co-receptors for MHC class II and class I, respectively (61). Rojas, 
et al., showed that although accessory cells promote proliferation and IFN-y production by yô 
T cells in response to live M. tuberculosis or purified phosphoantigens, APC with 
mismatched MHC molecules were potent stimulators of antigen-specific IFN-y production 
(95). It may be that antigen-specific responses require APC for full stimulation, but the 
stimulatory signals are not derived from interactions between the yô TCR with MHC 
molecules, yô T cell recognition of non-classical MHC-like molecules such as CDlc (107) 
and MICA (35) have also been described. 
Bovine WC1 
The surface antigen which divides bovine yô T cells into two subsets has been 
designated as Workshop Cluster 1 (WC1). WC1+ yô T cells lack the expression of CD2 and 
CDS (73), and are the predominant population of yô T cells in the peripheral circulation (28). 
In contrast, WC1- yô T cells are CD2+ and CD8+/- and are found in the red pulp of the spleen 
and in the intestine (73). Bovine WC1 is a 215-300 kDa cell surface glycoprotein with a 170 
kDa protein backbone (28, 138). yô T cells are the only cell type which expresses WC1 
(138). WC1 has 11 scavenger receptor cysteine-rich repeats with homology to the cell 
surface antigens CD5 and CD6 (138). WC1+ T cells express a ligand for E-selectin (62) and 
have a memory phenotype (CD45RO+) (7). Homologous WCl-like genes have also been 
found in sheep, goats, pigs, horses, mice, and humans (138), but gene expression is limited to 
ruminants. To date, a ligand for WC1 has not been found. 
WC1 has been suggested to have a role in tissue-specific migration of yô T cells 
(137), cell cycle regulation (117), and cytokine production (2). Antibody against WC1 
inhibited yô T cell proliferation and induced morphological changes in yô T cells; these 
morphological changes observed with WC1 binding may be important in yô T cell migration 
(117). Reversible growth arrest at G0/G1 phase was induced upon ligation of WC1; growth 
arrest could be reversed with stimulation through CD3 or with con A and addition of IL-2 
(117). It has been suggested that this may be a mechanism for maintaining a population of 
memory cells by preventing cells from entering apoptosis or proliferative stages (117). yô T 
cells have been shown to produce IFN-y in response to plate-bound anti-WCl; proliferation 
was not induced by ligation of WC1, suggesting that interaction with WC1 leads to 
expression of effector function rather than cellular proliferation (2). 
Immunoregulation of ap T cells by yô T cells 
A few studies have suggested crosstalk between yb T cells and a|3 T cells with yb T 
cells having a suppressive effect on a|3 T cell proliferation and cytokine production. In non-
antigen-primed mice treated with intraperitoneal administration of anti-yô TCR antibody, 
splenic and lymph node a|3 T cells showed unrestricted proliferation in the absence of 
stimulatory factors (67). CD4+ T cells from anti-yô TCR-treated mice, but not control mice, 
proliferated and produced IL-2; proliferation of CD8+ T cells also occurred in anti-yô TCR-
treated mice, and these CD8+ T cells differentiated into potent cytotoxic T lymphocytes in 
the absence of antigenic stimulation. These findings suggest that yb T cells can negatively 
regulate CD4+ T cell proliferation and the production of autoreactive CD8+ T cells (67). In 
cattle naturally infected with M. paratuberculosis, purified CD4+ T cells proliferated in 
response to antigen when cultured with irradiated APC; addition of purified yb T cells to 
these cultures eliminated antigen-specific CD4+ T cell proliferation (25). Similar 
immunoregulation has been found in cattle infected with M. bovis, where depletion of yb T 
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cells from PBMC cultures resulted in increased antigen-specific proliferation of the 
remaining PBMC, suggesting that yô T cells may exert a suppressive effect on a(3 T cells 
(94). 
Experiments in yb TCR knockout (KO) mice infected with L. monocytogenes have 
suggested that yb T cells play a role in regulating the formation of hepatic granulomas by ap 
T cells (77). yb TCR KO mice formed hepatic abscesses, rather than granulomas, suggesting 
that in the absence of yb T cells, aP T cells are not capable of inducing the granuloma 
formation seen in normal littermates (77). 
Downregulation of the immune response 
yb T cells have been implicated in downregulating the immune response following 
inflammation and elimination of the inciting agent. In mice, VylVô6.3 T cells are the 
predominant yb T cell subset in lymphoid tissues and the major yb T cell subset which 
produces IFN-y and accumulates at sites of Listeria monocytogenes infection (34). 
Experiments have demonstrated that the response of VylVô6.3 cells may provide a 
homeostatic mechanism to clear activated macrophages after the immune response (34). 
VylVô6.3 bind to activated, but not non-activated, peritoneal macrophages in a TCR-
dependent fashion. The ability to bind macrophages was not dependent on activation of the 
VylVÔ6.3 cells, as yô T cells from non-infected mice bound as effectively as those from L. 
monocytogenes-inîzcteà mice. Activated peritoneal macrophages were lysed by a Fas-Fas 
ligand interaction by VylVô6.3 T cells (33), again independent of activation status of the yb 
T cells. These yb T cells may be part of a regulatory loop to dampen inflammation, and 
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constant surveillance for activated macrophages may be the primary function of this yô T cell 
subset in mice. 
Granule-dependent cytotoxicity 
yô T cells have been shown to lyse target cells by a granule dependent pathway, and 
yô T cells can lyse infected cells even if not previously exposed to the infectious agent (88). 
yô T cells lysed herpes simplex virus-infected cells as well as cells infected with the 
unrelated vaccinia virus, suggesting that yô T cells recognize antigens altered by the cellular 
stress of infection rather than antigens from the infectious agent itself (16). Cytolytic 
function is not MHC class I or class II restricted, but blockage of CD3 or the yô TCR with 
monoclonal antibodies eliminates cytotoxicity (16). It has been proposed that the cytolytic 
function of yô T cells is designed to lyse non-activated, infected phagocytes early in infection 
for release of organisms to be taken up by activated macrophages (88). 
Epithelial repair 
Consistent with their proposed role in protection of epithelia, yô T cells have been 
shown to participate in wound repair and in maintaining the integrity of epithelial surfaces. 
Dendritic epidermal T cells (DETC), defined as intraepithelial yô T cells in the skin of mice 
that express the Vy3Vôl T cell receptor (11), recognize antigen from damaged or stressed 
keratinocytes and induce epithelial hyperplasia in damaged skin through the production of 
keratinocyte growth factors (KGF) 1 and 2 (58). yô T cells were localized to sites of 
intestinal mucosal damage in dextran sodium sulfate-treated mice; intraepithelial yô T cells in 
these mice expressed high levels of KGF in the area of mucosal damage (22). Mice lacking 
yô T cells had markedly delayed repair of ulcerated mucosa compared to their wild-type 
counterparts (22). 
yô T cells and macrophage activation 
Macrophage activation occurs following stimulation with pro-inflammatory 
cytokines, chiefly IFN-y (72). CD4+ T cells are considered the most significant producers of 
IFN-y for macrophage activation, but yô T cells and natural killer (NK) cells are also potent 
producers of IFN-y (9). Activation of macrophages leads to enhanced phagocytic and 
bactericidal activity, increased production of macrophage-derived cytokines (such as TNF-a 
and IL-1), and production of antimicrobial substances (such as oxygen radicals, nitric oxide, 
and lysozyme) (60). Despite their propensity towards a Thl-type response with IFN-y 
production, few studies have evaluated the role of yô T cells in the activation of 
macrophages. 
Nishimura, et al., demonstrated the ability of mouse yô T cells to upregulate 
macrophage TNF-a production in response to stimulation with LPS (81). In this study, 
macrophages from yô TCR KO mice were found to produce only small amounts of TNF-a in 
response to stimulation with LPS; preincubation of macrophages from yô TCR KO mice with 
yô T cells from heterozygous littermates resulted in markedly increased TNF-a production in 
response to LPS (81). Neutralizing anti-IFN-y antibodies inhibited the production of TNF-a 
by macrophage cultures containing yô T cells (81). The data suggest that murine yô T cells 
maintain macrophages in a primed state through the secretion of IFN-y such that further 
18 
stimulation by LPS results in production of TNF-a (81). Jones-Carson, et al., demonstrated 
enhanced macrophage nitric oxide (NO) production in the presence of yô T cells in mucosal 
infection with Candida albicans (63). Supematants from the co-culture of C. albicans-
responsive yô T cells and macrophages stimulated significant macrophage NO production; 
these supematants conferred significant macrophage candidicidal activity upon macrophages 
in vitro (63). Addition of anti-IFN-y antibody to in vitro cultures diminished these effects 
(63). In vivo depletion of yô T cells in this study resulted in decreased mucosal inducible 
nitric oxide synthase expression and increased susceptibility to mucosal candidiasis (63). 
Taken together, these studies suggest that mouse yô T cells are capable of providing the first 
signal for macrophage activation through their production of IFN-y. 
yô T cells and mycobacteria 
Introduction 
A role for yô T cells in the immune response to mycobacteria has been suggested by 
their accumulation in mycobacteria-infected tissues (75), their proliferation in response to 
mycobacterial antigens (13, 82, 94,128) including the 65 kDa heat shock protein of M. 
tuberculosis (14, 51) and small molecular weight non-protein antigens from M. tuberculosis 
culture lysates (29), and their secretion of cytokines, particularly IFN-y, when stimulated 
with mycobacterial antigens (45,46, 94,128). 
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Antigen recognition; non-peptide antigens 
Early work on antigen recognition by yb T cells revealed that some mycobacterial 
antigens were resistant to protease digestion and were of low molecular weight, 3 kDa or less 
(91, 92). One of the first such nonpeptide ligands recognized, tuberculosis antigen (TUBag) 
4, is a 5' triphosphorylated thymidine-containing compound of approximately 500 daltons 
(29). Three structurally related ligands, TUBag 1, TUBag 2, and TUBag 3, have also been 
characterized (29). 
Human yb T cells can detect nonpeptides with phosphoester bonds (phosphoantigens), 
although the mechanism of phosphoantigen recognition by the yb TCR is not understood 
(95). In contrast, mouse yb T cells do not recognize phosphoantigens (66, 131). 
Phosphoantigens recognized by human Vy9Vô2 T cells include tuberculosis antigens 1 and 2 
(TUBags 1-2) (95), TUBag 4 (29), isopentenyl pyrophosphate (IPP), 2,3-diphosphoglycerate, 
and glycerol 3-phosphate (95). An analog of IPP, bromohydrin pyrophosphate (BrHPP), has 
recently been synthesized and has stimulatory properties similar to IPP but at lower 
concentrations (95). 
Isopentyl pyrophosphate (IPP), a precursor of cholesterol synthesis that is shared 
among prokaryotes and eukaryotes (95), is one of the most extensively studied 
phosphoantigens. It is thought that IPP intermediates produced by prokaryotes can be 
distinguished from self-derived cholesterol biosynthetic products by Vy9VÔ2 T cells (95). 
Rhesus macaque Vy9Vô2 T cells proliferate vigorously in response to the IPP analogue 
monoethyl phosphate (MEP) (131). IPP is recognized by and induces proliferation of human 
yb T cell lines; APC are not required for stimulation but the presence of APC markedly 
enhances the ability of yb T cell lines to proliferate in response to IPP and MEP (79). 
Antigen presentation does not occur through classical pathways, as monoclonal antibodies 
against MHC class I, MHC class II, CD la, CD lb, and CDlc did not block this stimulatory 
capability (79). In addition, presentation did not require antigen uptake or processing, as 
paraformaldehyde-fixed APC retained the ability to stimulate yô T cells (79). However, 
antigen:APC interactions were not stable, as APC could not be effectively pulsed with prenyl 
pyrophosphates and the continuous presence of antigen in culture was required for T cell 
activation and proliferation (79). 
yô T cells isolated from peripheral blood (i.e., predominantly WC1+ yô T cells) from 
healthy cattle do not respond to stimulation with IPP (94, 128); however, peripheral blood yô 
T cells from cattle infected with M. bovis do proliferate in response to IPP (135). Bovine 
peripheral blood yb T cells also recognize a non-peptide component of mycobacterial cell 
walls (128). Cell wall extract from M. tuberculosis and M. bovis induced production of IFN-
Y by purified yb T cells cultured in the presence of monocytes; proteolysis of the cell wall 
extract did not diminish IFN-y production (128). Components of the cell wall extract were 
tested for their ability to induce IFN-y secretion by yb T cells; the lipid fraction did not 
stimulate IFN-y production, but stimulation with mycolylarabinogalactan peptidoglycan from 
M. tuberculosis induced similar levels of IFN-y secretion as that induced by stimulation with 
protease-treated cell wall extract (128). 
Antigen recognition: protein antigens 
In several studies, human and murine yb T cells have been shown to be stimulated by 
the 65 kilodalton mycobacterial heat shock protein (Hsp65) (14, 51, 82), although in other 
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studies responses by yb T cells were minimal (65,91). Hsp65 is an immunodominant antigen 
with epitopes recognized by a0 T cells as well as B cells (14). These proteins are relatively 
well-conserved across prokaryotes and eukaryotes, and are synthesized in response to sudden 
temperature increases and other stressors (51). Hsp65 is found in high concentrations in 
mycobacterial PPD (82). Using synthetic peptides, a peptide fragment of Hsp65 identical in 
M. leprae, M. tuberculosis, and M. bovis stimulated IL-2 release by yb T cells (14). Peptide 
fragments from homologous regions in human Hsp65 also stimulated yb T cell hybridomas 
(14), suggesting recognition of self heat shock proteins during cellular stress. In one study 
(51), a yô T cell line responded to Hsp65 when matched with autologous APC, but not those 
mismatched for HLA, suggesting antigen recognition in the context of major 
histocompatability complex molecules, although in another study, blocking of MHC I and 
MHC II with antibody did not diminish the response by yb T cell hybridomas (82). It has 
been speculated that because prokaryotic and eukaroytic heat-shock proteins are similar 
antigenically, yb T cells may have a role both in recognizing damage to self as well as 
invasion by microorganisms (51). 
Other mycobacterial protein antigens recognized by yb T cells include the Antigen 85 
complex (Ag85A, B, and C), ESAT-6, and M. bovis PPD in cattle (94), and a 10-14 kDa cell-
associated protein antigen from M. tuberculosis H37Ra which stimulates human yb T cells 
(13), 
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Vy9VÔ2 T cells 
In humans, the most prevalent and most well-studied subset of yô T cells is the subset 
bearing the Vy9Vô2 T cell receptor (also referred to as Vy2Vô2 T cells (131)). Fifty to 95% 
of peripheral blood yb T cells in healthy adult humans express the Vy9Vô2 heterodimer (66, 
89), although Vy9Vô2 T cells are only a minor subpopulation in the human thymus (87). 
Vy9VÔ2 T cells are the predominant yb T cell subset that responds to M. tuberculosis (64, 
83). After stimulation of PBMC with M. tuberculosis there was selective expansion of yb T 
cells from 0.3% of total PBMC to 45% of all responding cells, and all proliferating yb T cells 
expressed the Vy9 and VÔ2 heterodimer (64). Although mycobacteria-responsive yb T cells 
preferentially use the Vy9 and VÔ2 gene segments, there is diversity at the V-J junctions 
(complimentarity determining region 3 or antigen-recognition site) generated by numerous 
nucleotide additions and deletions, in both the y and ô chains (83). Vy9 preferentially pairs 
with the JyP segments, and VÔ2 is frequently found in association with the DÔ3 and Jôl or 
JÔ3 gene segments (83). There is no counterpart of the Vy9Vô2 T cell in species other than 
primates thus far evaluated, including the mouse, rat, rabbit, guinea pig, or in ruminants; 
these species do not have genes homologous to the Vy9 or VÔ2 genes (131). Rhesus 
monkeys have Vy9Vyô2 T cells with antigen specificity and genetic organization similar to 
humans and are the most appropriate animal model to study human Vy9VÔ2 T cells (131). 
Vy9Vô2 T cells have been shown to generate an adaptive immune response to M. 
bovis BCG in the rhesus macaque (104). During M. bovis BCG infection, there was a 
primary expansion of Vy9Vô2 T cells 3-5 weeks after infection. There was an increase in 
Vy9VÔ2 T cells in the lung and duodenal mucosa, but not in lymph nodes, after intravenous 
infection, suggesting a role for these cells in sites of environmental contact. When M. bovis 
BCG was inoculated a second time, there was rapid expansion of Vy9Vô2 T cells within 4-6 
days post-infection which persisted as long as seven months after the second infection. 
Expansion of Vy9Vô2 T cells was associated with decreasing M. bovis BCG bacteremia 
(104). 
Vy9VÔ2-expressing yô T cells have been shown to kill intracellular and extracellular 
M. tuberculosis through a granule-dependent pathway (38, 39). Perforin was required for 
killing of intracellular M. tuberculosis, and granulysin was capable of killing both 
intracellular and extracellular organisms (39). Cytotoxic activity was abrogated by 
antibodies against the T cell receptor (39). Vy9Vô2 cells were shown to kill M. tuberculosis-
infected macrophages using granzyme A (38); release of intracellular organisms could then 
be susceptible to killing by granulysin. Killing of infected macrophages was not MHC class 
I or class II restricted but did involve interactions with the yô T cell receptor (38). 
The ability of yô T cells to reduce the viability of intracellular mycobacteria has been 
recently called into question. Although Dieli et al. found that Vy9Vy2 T cells could reduce 
the viability of intracellular mycobacteria by 20-35% (38) and 25-55% (39), Passmore et al. 
did not find such a reduction by yô T cell clones cocultured with M. tuberculosis-infected 
U937 macrophages (88). Passmore et al. (88) suggested several possibilities for this 
discrepancy. One possibility was that washing of infected macrophages after culture with yô 
T cells by Dieli et al. may have washed away bacilli that were freed by yô T cell-mediated 
cytolysis, reducing the final bacterial count. Passmore, et al. (88) pooled the cell lysate and 
the supernatant to account for bacilli released by cytolysis. Secondly, Passmore et al. (88) 
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opsinized mycobacteria with immune human serum, whereas Dieli et al. (38) used 
nonopsinized bacteria. Serum opsinized mycobacteria are taken up via the Fc and 
complement receptors, while nonopsinized mycobacteria are taken up by the mannose, 
complement, and scavenger receptors (88). Passmore et al. (88) noted the difference in the 
phagosomal compartment in which the mycobacteria reside when taken up through different 
receptor pathways, and this difference may affect the susceptibility of the mycobacteria in 
different phagosomal compartments to granule-mediated killing. 
Bovine y ô T cells and mycobacterial infection 
WC1+ Y& T cells have been shown to be involved in the immunologic response to 
Mycobacterium bovis. In support of the theory of WC1+ yb T cells providing a first line of 
immunological defense against intracellular pathogens, WC1+ cells were among the first to 
infiltrate DTH sites of Mycobacterium 6ov/s-infected cattle, comprising the majority of 
lymphocytes present in the skin at the site of PPD deposition during the first 6-24 hours (40). 
WC1+ yb T cells were present during the first 21 days post-infection within the lymphoid cuff 
surrounding the core of M. bovis granulomas in experimentally-infected cattle, suggesting a 
immunoregulatory function for the developing granulomas (19). WC1+ T cells from 
experimentally-M bovis infected cattle upregulated the IL-2R and proliferated vigorously in 
vitro when cultured in the presence of M. bovis antigens (106). There was rapid and 
sustained expression of IL-2R; after 24 hours of culture with M. bovis antigens 
approximately 90% of WC1+ T cells expressed the IL-2R and expression remained high 
through 168 hours in culture (106). WC1+ T cells from M. ôov/s-infected cattle proliferate 
and produce IFN-y in response to a purified protein antigen (ESAT-6) of M. bovis and 
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proliferate in response to non-protein antigens produced by mycobacteria (IPP and 
monomethyl phosphate) (135). 
A role for regulation of the immune response to M. bovis by WC1+ yô T cells has 
been suggested by experiments in which calves were depleted of WC1+ cells (69). Calves 
depleted of WC1+ cells had relatively greater numbers of circulating CD4+ T cells compared 
to non-depleted calves (69). WC1+ T cell-depleted calves had lower proliferative responses 
to M. bovis PPD compared to non-depleted calves (69). Animals depleted of WC1+ cells had 
significantly greater production of the Th2 cytokine IL-4, less IgG2a production, and 
essentially no IgG2 production, suggestive of a Th2-like bias in the immune response (69). 
Taken together, the data suggest that WC1+ yô T cells have a role in driving the predominant 
immune response to M. bovis in cattle to a Thl-type response. 
Data regarding yb T cells in M. paratuberculosis-infected calves suggests less of a 
role for yb T cells in controlling infection (6). Although purified peripheral blood yb T cells 
from M. paratuberculosis-infected calves proliferated in response to M. avium-PPD antigen, 
CD4+ T cells, but not yb T cells, produced IFN-y in response to antigenic stimulation. If yb T 
cells play a role in bovine paratuberculosis, it is not likely in the production of IFN-y (6). 
Granuloma formation and organization in mycobacterial infection 
Several studies using yô TCR KO mice have suggested a role for yb T cells in the 
formation and organization of granulomas during mycobacterial infection (31, 98,119). 
These results are often conflicting and suggest different actions by yb T cells or by different 
yb T cell subsets during specific mycobacterial infections, yb TCR KO mice infected with M 
tuberculosis had larger granulomas which had fewer lymphocytes and less organization than 
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wild-type mice (31). Compared to the lesions in wild-type mice, which were composed of 
epithelioid macrophages and multinucleated giant cells intermixed with lymphocytes, the 
inflammation in yô TCR KO mice was composed of larger coalescing areas of 
pyogranulomatous inflammation containing abundant neutrophils. In contrast, yô TCR KO 
mice infected with M. avium strain 724 developed granulomas with fewer neutrophils and 
increased numbers of lymphocytes and lacking the prominent central areas of necrosis seen 
in wild type mice (98). In both studies, bacterial loads were similar between yb TCR KO 
mice and wild-type mice, yb TCR KO mice inoculated with a high dose of M. 
paratuberculosis had decreased size and numbers of hepatic granulomas with a decreased 
bacterial load in the spleen compared to wild-type mice (119). Inflammation in yb TCR KO 
mice lacked the epithelioid macrophages and multinucleated giant cells seen in wild-type 
mice. 
Conflicting evidence 
The contribution of yb T cells to processes leading to either the resolution or 
exacerbation of mycobacterial disease is unknown. While the conserved recognition of 
mycobacterial antigens and the production of IFN-y by yb T cells seem to suggest a 
protective role during active mycobacterial disease, the potentially pathologic effects of this 
T cell subset on the immune response to intracellular pathogens have not been thoroughly 
investigated. A study of M. avium infection in yb TCR KO mice suggests that highly virulent 
M. avium strains induce greater tissue destruction in the presence of yb T cells (98). The 
authors hypothesized that macrophages recruited to the site of active inflammation by yb T 
cells (prior to macrophage activation by a|3 T cells) may exacerbate the infection by 
providing additional host cells for the pathogen (98). Data from a recent study on M. 
paratuberculosis infection in mice suggests improved bacterial clearance from spleens of yb 
TCR KO mice compared to heterozygous controls (119). These studies are at least 
suggestive of potential interference by yb T cells to the development of a protective immune 
response to mycobacteria. 
Interactions between M. paratuberculosis and macrophages 
Entry of M. paratuberculosis into macrophages 
M. paratuberculosis enters the subepithelial region of the ileum by passing through M 
cells overlying the dome epithelium (78). At least two attachment proteins for M. 
paratuberculosis have been described. A homologue of the fibronectin attachment protein 
(FAP) of M. avium has been characterized in M. paratuberculosis which binds fibronectin in 
acid pH (101). M. paratuberculosis becomes activated to bind fibronectin during passage 
through the acidic environment of the abomasum, and bacilli are opsonized by fibronectin in 
the bile present in the duodenum (101). M cells express fibronectin binding sites (including 
the a5pl and the cxV|33 integrins) on their apical surfaces which can bind M. 
paratuberculosis through the FAP-fibronectin complex (102). A 35 kDa cell surface protein 
homologous to an immunodominant protein present in M. leprae and M. avium has also been 
described in M. paratuberculosis, which plays a role in cell invasion (3,4). After receptor-
ligand interactions between the bacteria and the intestinal epithelium, M cells take up the 
bacteria, transport them through the epithelial barrier, and present them to macrophages 
within the subepithelial region (78). Recognition of M. paratuberculosis for internalization 
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into phagosomes by macrophages has been described for at least two receptors: the mannose 
receptor and the complement receptor. Pathogenic and nonpathogenic mycobacteria can be 
recognized by the mannose receptor on macrophages, and phagocytosis associated with this 
receptor does not elicit the production of superoxide (1). Antibody blocking studies have 
shown that M. paratuberculosis can be recognized by complement receptor (CR) 3 (23), 
although the intracellular fate of M. paratuberculosis taken up by this pathway has not been 
described. Other receptors described for entry of other mycobacteria into macrophages 
include CR1 and CR4, immunoglobulin receptors (FcR), CD 14, transferrin receptors, and 
scavenger receptors (105). 
Survival of M. paratuberculosis in macrophages 
M. paratuberculosis, like other mycobacteria, resides and replicates within 
macrophages (5). Phagocytotic vesicles normally develop by fusion with endocytic and 
exocytic vesicles for bacterial degradation (123). After phagocytosis, a proportion of M. 
paratuberculosis are killed (5, 55), while some bacteria resist degradation and proliferate 
(142). Intact and degraded M. paratuberculosis have been observed in bovine macrophages 
in vitro and in macrophages from the intestines of infected cattle (8). Mycobacteria have 
developed strategies for surviving and replicating within the harsh environment of host 
phagocytes. Two such strategies include reduced acidification of bacteria-containing 
vesicles and interference with the development of functional phagolysosomes. There is 
evidence that both of these strategies are utilized by M. paratuberculosis. 
Phagosomes containing M. tuberculosis or M. avium fail to fully acidify to form 
lysosomal compartments. A series of experiments using M. tuberculosis and M. avium-
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infected macrophages and pH-dependent antibiotics demonstrated that mycobacteria reside in 
vesicles which are not acidic (30). Pyrazinamide, which is effective at acid pH, effectively 
kills intracellular mycobacteria, whereas streptomycin, which is ineffective at low pH, fails 
to kill mycobacteria. This was previously considered evidence for acidification of 
mycobacteria-containing vacuoles; however, addition of chloroquine or ammonium chloride 
to the infected macrophages to raise the pH of intracellular vesicles in these experiments had 
no effect on anti-mycobacterial killing (30). In addition, immunoelectronmicroscopy for 3-
(2,4-dinitroanilino)-3'-amino-./V-methyl dipropylamine (DAMP), a weak base which 
accumulates in acidic vacuoles, showed no correlation between DAMP accumulation and 
vesicles containing M. tuberculosis or M. avium (30). Compared to phagosomes containing 
Leishmania mexicana or the yeast cell wall extract zymosan, which maintained a pH below 
5.5, phagosomes containing M. avium maintained a pH of 6.5 (115). Such an increase in 
phagosomal pH would likely limit lysosomal hydrolase activity (115). Although there is 
mixing of phagosomal and endosomal compartments, as suggested by the presence of the late 
endosomal/lysosomal marker, lysosomal-associated membrane protein-1 (LAMP-1), on 
vesicles containing M. avium, mycobacteria exclude the vesicular proton-adenosine 
triphosphatase (ATPase) which acidifies vesicles (115). Although such detail regarding 
failure of vacuolar acidification has not been described for M. paratuberculosis in bovine 
macrophages, it has recently been shown that mRNA for the vacuolar proton-ATPase is 
significantly downregulated in bovine monocyte-derived macrophages infected with M. 
paratuberculosis ( 134). 
Phagosomes fuse with lysosomes and accumulate markers from the endosomal 
compartment to become phagolysosomes (129). During this developmental pathway, early 
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proteins accumulate and then are lost, to be replaced by late markers (55). Phagosomes 
containing live M. tuberculosis contain high levels of transferrin receptor (TFR), a marker of 
early endosomes, and low levels of LAMP-1, a late phagosomal marker, and the lysosomal 
acid hydrolase cathepsin D (27). In contrast, phagosomes containing heat-killed M 
tuberculosis have markedly increased amounts of LAMP-1 and cathepsin D (27). 
Phagosomes containing live M. tuberculosis did not fuse with secondary lysosomes labeled 
with bovine serum albumin-gold, although vesicles containing polystyrene beads did fuse 
with these vesicles (27). Others have studied the sequential accumulation, loss, and 
replacement of endosomal-lysosomal regulatory proteins on the developing mycobacterial 
phagosome. One family of such markers include the rab proteins, small molecular weight 
ras-like guanosine triphosphate binding proteins which regulate membrane trafficking (127, 
129). Experiments comparing phagocytosis of M. bovis-BCG and latex beads have shown 
that M. bovis-BCG phagosome maturation is blocked between the stages controlled by rab5, 
which controls early endosome fusion (49), and rab7, a regulatory protein for late endosomes 
(41). Other, non-protein markers of phagolysosomal development have recently been 
investigated. Phosphatidylinositol 3-phosphate (PI3P), a lipid which regulates membrane 
trafficking for accumulation of lysosomal components on phagosomes, has been shown to 
accumulate on phagosomes containing heat-killed M. tuberculosis, but is absent from 
phagosomes containing live bacteria (127). It has also been shown that M. tuberculosis 
produces a phosphatase that dephosphorylates PI3P, thereby inhibiting formation of late 
endosomes (127). Although less is known about phagosomes containing M. 
paratuberculosis, it has recently been shown that M. paratuberculosis phagosomes have high 
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levels of transferrin receptor, a marker of early endosomes, and low levels of LAMP-1, a late 
phagosomal marker (55), as observed for vesicles containing M. tuberculosis (27). 
Cytokine effects on M. paratuberculosis-infected macrophages 
Several studies have shown that treatment of mycobacteria-infected macrophages 
with Thl cytokines can overcome the failure of phagolysosomal maturation and lead to 
increased phagosomal acidification. Macrophage activation requires the Thl cytokine IFN-y 
and a second signal through TNF-a, which can be induced through LPS stimulation (99). 
Data from studies using murine macrophages infected with mycobacteria suggest that 
treatment of macrophages with IFN-y and LPS leads to increased killing of intracellular 
bacilli (54,99). Murine J774 cells activated by pretreatment with recombinant IFN-y and E. 
coli LPS prior to infection with M. paratuberculosis had increased percentages of bacteria 
within acidified vacuoles compared to infected, non-activated macrophages (54). IFN-y/ 
LPS-treated macrophages had increased colocalization of M. paratuberculosis with the late 
endosomal marker LAMP-1 compared to non-activated infected macrophages (54). The data 
suggest that activation of macrophages prior to infection may reverse the defect in 
phagolysosomal development caused by infection with live M. paratuberculosis (54). 
Murine bone marrow-derived macrophages infected with M. avium were unable to restrict 
bacterial viability unless treated with IFN-y and LPS (99). Whereas M. avwm-containing 
phagosomes maintain a pH of 6.5 (115), similar phagosomes in IFN-y/LPS-activated 
macrophages have a pH of 5.2 (99). This phagosomal acidification is brought about by the 
recruitment of the vacuolar proton ATPases (99). Transferrin was not present on these 
phagosomes, suggesting development away from the early endosome/phagosome phase that 
32 
was observed in resting macrophages (99). When mouse bone marrow-derived macrophages 
and J774 cells were infected with M. bovis BCG, few bacilli colocalized with acidified 
compartments; treatment of macrophages with IFN-y and LPS substantially enhanced 
colocalization (130). 
Studies on cytokine regulation of the intracellular growth of M. paratuberculosis in 
bovine macrophages have shown less of a bactericidal effect by IFN-y. Zhao, et al. 
demonstrated that the extent of bacterial killing depended on the timing and dose of 
recombinant IFN-y administered to bovine monocyte-derived macrophage cultures (141). In 
untreated macrophages, the number of M. paratuberculosis recovered from infected cultures 
increased approximately threefold over the course of infection. Macrophage cultures 
exposed to IFN-y only before or only after infection had increases in M. paratuberculosis of 
approximately twofold. In contrast, macrophage cultures exposed to IFN-y continuously 
before and during infection had no significant increases in numbers of M. paratuberculosis 
recovered (141). Culture supematants containing IFN activity (elicited by infection of 
PBMC with bluetongue virus) as well as recombinant IFN-a enhanced the ability of freshly 
isolated bovine monocytes to kill M. paratuberculosis, but killing was not increased by these 
cytokines or by recombinant IFN-y in monocyte-derived macrophages (143). 
The effect of antiinflammatory-type cytokines on M. paratuberculosis-'mfected. 
macrophages has received considerably less attention. Among them TGF-P and IL-10 have 
recently been studied. TGF-P deactivates macrophages, both by inhibiting the generation of 
reactive oxygen species and reactive nitrogen intermediates, and by counteracting the effects 
of IFN-y and TNF-a (124). In human patients with pulmonary tuberculosis, blood 
monocytes expressed more TGF-p than did monocytes from control patients (125). Within 
the pulmonary granulomas in these tuberculous patients, TGF-p expression was strong in the 
multinucleated giant cells and in epithelioid macrophages (125). In unfractionated PBMC 
cultures supplemented with TGF-P and infected with M. paratuberculosis, there was a 
significant reduction in bacterial killing compared to untreated, infected PBMC (70). IL-10 
also counters the effects of Thl cytokines on macrophages. IL-10 added to human monocyte 
cultures activated with IFN-y and LPS caused a downregulation in transcription of IL-1, IL-6, 
IL-8, TNF-a, and GM-CSF (36). In addition, IL-10 can inhibit the stimulatory ability of 
macrophages on cytokine production from Thl cells (44). Similar to TGF-p, addition of 
exogenous IL-10 to M. paratuberculosis-infected unfractionated PBMC cultures resulted in 
decreased bacterial killing compared to untreated, infected PBMC (70). Non-activated bone 
marrow-derived macrophages from IL-10 KO mice had a significantly higher frequency of 
colocalization of M. bovis BCG and acidified vacuoles compared to wild-type controls, 
suggesting that IL-10 may have a substantial role in modulation of the mycobacterial 
phagosome (130). TGF-P and IL-10 have a negative influence on IFN-y production by 
PBMC stimulated by live M. paratuberculosis (70), which may be one mechanism of action 
of these antiinflammatory cytokines. 
Classical mediators of killing by activated macrophages 
When activated by IFN-y-producing CD4+ T cells, macrophages upregulate the 
production of microbicidal substances, such as reactive nitrogen intermediates (RNI) and 
reactive oxygen species (ROS) for destruction of intracellular pathogens (60). Homodimeric 
IFN-y associates with the IFN-y receptor on the macrophage, which brings together the 
receptor-associated cytoplasmic Janus kinase (JAK)-l and JAK-2 (60,72). IFN-y binding 
results in receptor phosphorylation, which then leads to binding of cytosolic signal transducer 
and activator of transcription (STAT) la, which is in turn, phosphorylated by the JAKs (60, 
72). Phosphorylated STAT la is released and is translocated to the nucleus, where it binds 
the gamma activated site for initiation of gene transcription (72). IFN-y acts in concert with 
tumor necrosis factor to upregulate the expression of proinflammatory genes via receptor 
interacting protein-dependent activation of nuclear factor (NF)-KB (72). 
In this manner, IFN-y stimulates the expression of the enzyme inducible nitric oxide 
synthase (iNOS) by macrophages (74). Mice deficient in IFN-y (32) or the IFN-y receptor 
(56) produce low levels of nitric oxide (NO) in response to activating stimuli. Within the 
macrophage, iNOS catalyzes the conversion of oxygen and L-arginine to AT-hydroxy-L-
arginine, then to citrulline and NO (10). NO can further react in water with oxygen and its 
intermediates to yield nitrogenous isoforms, including N02, N02\ NO/, N203, and 
peroxynitrite (ONOO ) (74). Nitric oxide and its derivatives have cytostatic or toxic activity 
against bacteria, viruses, intracellular and extracellular parasites, and neoplastic cells (74). 
Several lines of evidence suggest that NO is an important product of macrophages 
involved in host defense. Increased expression of iNOS correlates with resistance to 
microbial growth, and iNOS deficiency allows pathogen growth in some systems (74). 
Expression of iNOS by macrophages in cutaneous lesions and draining lymph nodes of 
C57BL/6 mice infected with Leishmania major correlated with the absence of parasites at 
these sites (114). Inhibition of iNOS by L-A^-iminoethyl-lysine (L-NIL) in vivo in mice 
infected with L. major led to a four- to five-fold log increase in parasite burden (112). 
Murine macrophages activated by IFN-y and LPS or TNF-a inhibit the growth of M. 
tuberculosis through the production of NO (21). Administration of iNOS inhibitors to M. 
tuberculosis-infected mice led to rapid mortality and increased bacterial burden in tissues 
(20). 
In contrast to these studies, it has been shown both in vitro and in vivo that killing of 
M. avium in the mouse is not dependent on NO, and that, in fact, the immunoregulatory 
effects of NO exacerbate M. avium infection. Bone marrow-derived macrophages from 
iNOS-/- mice killed M. avium as efficiently as macrophages from wild-type 129 SV mice; 
treatment of infected macrophages from both strains with IFN-y and TNF-a resulted in 
increased bacterial killing (48). In vivo, wild-type and knockout mice controlled an 
intravenous M. avium infection equally well at early time points (up to two months), but at 
later time points (four months), iNOS-/- mice controlled the infection more efficiently than 
129 Sv mice (48). Early in the infection, the spleens from 129 Sv mice had higher CD4+ T 
cell counts than the iNOS-/- mice, but at four months lymphocytes from iNOS-/- mice 
produced more IFN-y during the recall response (48). NO inhibits IFN-y production by Thl 
clones (120), and the lack of NO in iNOS-/- mice may have resulted in a stronger Thl 
response. 
A similar lack of killing by NO may occur in bovine infection with M. 
paratuberculosis. Although stimulation of M. paratuberculosis-infected bovine 
macrophages with IFN-y increased the production of nitric oxide, and addition of N°-
monomethyl-L-arginine (NMMA) to these cultures blocked its production, neither increases 
in nor inhibition of nitric oxide production correlated with bacterial survival (141). In 
addition, a cell-free system was used to demonstrate that greater than 270 pM of nitric oxide 
is required to effect a log reduction in bacterial survival, a concentration which is not likely 
achievable in vivo (141). 
Activation of macrophages also leads to the production of reactive oxygen species 
(ROS). The most well-studied ROS include superoxide (02~) and hydrogen peroxide (H202). 
Superoxide is produced by NADPH oxidase, a multi-protein complex assembled on 
phagosomal membranes (37). These proteins are separated into cytoplasmic and membrane 
components, and upon macrophage activation, the cytoplasmic proteins translocate to the 
phagosomal membrane where they interact with the membrane components, forming the 
active complex. NADPH oxidase transfers electrons to oxygen to produce 02, which is 
relatively short-lived and weakly bactericidal, but is readily converted to other, more toxic 
species, including H202, hydroxyl radical (OH), and hypochlorous acid (HOC1) (37). The 
role of ROS in mycobacterial killing by activated macrophages is uncertain. Murine 
macrophages do not appear to use ROS to kill virulent M. tuberculosis, as the ROS 
scavengers superoxide dismutase, catalase, manntiol, and diazabicyclooctane did not reduce 
mycobacterial killing by macrophages (21). Infection of bovine macrophages with M. 
paratuberculosis does not appear to stimulate the respiratory burst (143). The amount of 
superoxide anion released from M. paratuberculosis-infected macrophages was not different 
from that released by uninfected macrophages, and treatment of infected cultures with IFN-y 
did not increase superoxide production (143). M. tuberculosis appears relatively resistant to 
killing by H202, as M. tuberculosis survived H202 concentrations which readily killed 
Leishmania donovani in a cell-free system (21). Further support for resistance of 
mycobacteria to H202 is the presence of a peptidoglycolipid known as macrophage inhibitory 
factor (MIF)-A3 within the cell wall of M. avium strain 18, which acts as an H202 scavenger 
with activity similar to catalase (100). 
The mechanism of killing of M. paratuberculosis has not been defined 
Although macrophages are the host cell for survival of M. paratuberculosis, killing of 
M. paratuberculosis by macrophages has been demonstrated (5,55). The mechanisms by 
which macrophages kill M. paratuberculosis have yet to be fully elucidated. Work in murine 
macrophages suggests that cytokine-mediated activation leads to increased phagosomal 
maturation and acidification and decreased survival of mycobacteria. Because M. bovis BCG 
does not colocalize in acidic compartments in murine bone marrow-derived macrophages, 
and treatment with IFN-y and LPS substantially enhances the colocalization, the data suggest 
that a mechanism of anti-mycobacterial action for IFN-y is through increased acidification of 
vacuoles (130). IFN-y treatment of murine bone marrow-derived macrophages or J774 cells 
led to increased colocalization of M. tuberculosis with vacuoles having an acidic pH (130). 
Similarly, vesicles containing M. avium in IFN-y-activated murine bone marrow-derived 
macrophages had a decreased pH compared to M. av/wm-containing vesicles in non-activated 
macrophages (99). Recently, it has been shown that IFN-y and LPS activation of M. 
paratuberculosis-'mÎQCteà J774 cells leads to colocalization of bacilli within acidified 
compartments containing LAMP-1, with a resultant decreased survival of M. 
paratuberculosis (54). Such studies have yet to be performed using bovine macrophages. It 
may be yet found that the pH of phagolysosomal compartments and the activity of vesicular 
proteases and hydrolases may be more important for the killing of M. paratuberculosis that 
the classical mediators of killing of intracellular pathogens. 
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Abstract 
Objective—To characterize the early cellular immune response to Mycobacterium avium 
subsp paratuberculosis (MAP) infection and evaluate the development of granulomatous 
inflammation at the subcutaneous (SC) injection site in experimentally inoculated calves. 
Animals— 48 four-week-old calves. 
Procedure—Calves received an SC injection of MAP strain 19698 (n = 25), sterile saline 
(0.9% NaCl) solution (20), or a commercial paratuberculosis vaccine (3); the inoculation site 
tissue and associated draining lymph node were excised at post-inoculation day (PID) 0 (n = 
36), 7 (14), 14 (6), 21 (8), and 60 (32). Sections of inoculation site tissues were evaluated 
immunohistochemically for T cell subsets; lymph node mononuclear cells (LNMCs) were 
assessed for T cell surface markers and for intracellular interferon-^ via flow cytometry. 
Results—At MAP inoculation sites, calves developed mild, focal granulomatous 
inflammation by PID 7; by PID 60, areas of inflammation contained macrophages with 
numerous lymphocytes. Compared with control calves, there was increased antigen-specific 
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LNMC proliferation in MAP- and vaccine-inoculated calves at PID 60, although proliferation 
among lymphocyte subsets was not significantly different between MAP-inoculated and 
control calves; in vaccine-inoculated calves, CD4+ T cells predominated. In MAP-inoculated 
and control calves, antigen-specific interferon-y production by LNMCs did not differ 
significantly; vaccine-inoculated calves had marked interferon-y expression by CD4+ T cells. 
Conclusions and Clinical Relevance—In calves, SC administration of MAP resulted in 
granulomatous inflammation at inoculation sites and an antigen-specific T cell proliferative 
response. Results suggest that this experimental system can be used to reproducibly generate 
antigen-specific T cells during MAP infection for functional analysis. 
Introduction 
Paratuberculosis (Johne's disease) is a chronic granulomatous enteritis of ruminant 
species caused by Mycobacterium avium subsp paratuberculosis (MAP). Mycobacterium 
avium subsp paratuberculosis is transmitted from infected cattle to calves mainly through 
fecal contamination within the environment; in some animals, infection apparently does not 
become established,1 whereas in others, a long nonclinical phase of the disease ensues during 
which time organisms can be intermittently shed in the feces.2 Clinical features of advanced 
Johne's disease include cachexia despite normal appetite, profuse diarrhea with fecal 
shedding of organisms, hypoproteinemia, and decreased milk production.2 
In the intestinal tract of cattle, MAP elicits granulomatous inflammation with 
infiltration of the ileum and adjacent intestine and regional lymph nodes with large numbers 
of epithelioid macrophages and multinucleated giant cells intermixed with lymphocytes.1 The 
cellular response to mycobacteria, including MAP,3 involves interaction between 
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macrophages and interferon (IFN)-Y-producing CD4+ T cells,4 as well as yô T cell receptor 
(TCR)+ T cells and CD8+ T cells.3 Although much is known about the cellular response to 
infection with MAP and other pathogenic mycobacteria, there is a lack of understanding 
regarding the failure of some animals to generate an effective immune response against 
mycobacterial agents; similarly, it is not known why some exposed animals apparently do not 
become infected1 yet others undergo reactivation of latent infection and progress to clinical 
disease.4 
The lesions of paratuberculosis continue to be difficult to reproduce experimentally. 
After oral administration of MAP and being housed for as long as 13 months, only 8 of 26 
experimentally-inoculated calves had lesions of Johne's disease detected histologically in the 
intestine and mesenteric lymph nodes, although MAP could be grown on culture of intestinal 
mucosal scrapings from 25 of 26 calves.5 Several models of Johne's disease in mice have 
been developed to study the granulomatous inflammation caused by MAP.6"9 Although 
models of other mycobacterial infections in rodents appear to mimic the pathologic and 
immunologic course of mycobacterial disease in humans,10 the classic enteric lesions 
associated with paratuberculosis in ruminants are lacking in experimentally-infected mice, 
and it has been suggested that the usefulness of murine models may instead lie in the 
evaluation of potential antimycobacterial chemotherapies.6 
Understanding the development of granulomatous inflammation and the cellular 
immune response to MAP infection in cattle will ultimately require development of a 
reproducible experimental infection system. The objective of the study reported here was to 
characterize the early cellular immune response to MAP infection and evaluate the 
development of granulomatous inflammation at the site of SC injection in calves 
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experimentally inoculated with MAP. 
Materials and Methods 
Experimental design and animals—All animal-related protocols in this experiment 
were approved by the Committee on Animal Care at Iowa State University. Colostrum-fed 
Holstein calves (47 male and 1 freemartin female) were purchased from the Iowa State 
University Dairy Farm (Ankeny, Iowa) within the first week after birth. There had been no 
clinical cases of paratuberculosis in this herd during the 5 years preceding this study; results 
of both cultures of feces and MAP antibody ELISAs performed on samples obtained from 
cows in this herd with chronic diarrhea were consistently negative for paratuberculosis 
infection. Physical examinations (including rectal temperature, heart and lung auscultation, 
joint palpation, rumen auscultation) were performed on all calves prior to entry into the 
study. Rectal temperatures were obtained at PID 0, 1,3, 7, 14, and 60. 
At 4 to 5 weeks of age, calves were inoculated SC with MAP (n = 25), sterile saline 
(0.9% NaCl) solution (20), or a commercial paratuberculosis vaccine8 containing killed M 
avium in oil adjuvant (3) in the cervical region at a site which drains into the superficial 
cervical lymph node. The day of inoculation was designated as day 0. Calves were housed 
in concrete and steel pens either singly or in groups of 2 (and if paired, both animals received 
the same inoculum). Delayed-type hypersensitivity (DTH) testing of calves inoculated 
with MAP (n = 13), saline solution (7), or vaccine (3) was performed at post-inoculation 
day (PID) 60 or PID 90 by use of standard procedures with a purified protein derivative 
(PPD) of the MAP type strain."* The PPD injections were administered ID in the cervical 
region in a site several centimeters from the original site of inoculation with MAP, saline 
solution, or the vaccine. Prior to and 72 hours after ID injection of PPD, skin thickness at the 
injection site was measured. At the termination of the experiment, each calf was 
euthanatized via IV administration of an overdose of pentobarbital, and a complete necropsy 
was performed. 
Inocula preparation—The MAP strain 19698 was maintained in Middlebrook 7H9 
broth supplemented with mycobactin J. To prepare aliquots for inoculation, bacteria were 
washed and resuspended in sterile saline solution, and the concentration of organisms was 
estimated by measuring the absorbance at 540 nm and comparing the absorbance against a 
standard curve as previously described.6 Each dose for inoculation was adjusted to a 
concentration of 1 X 108 CPUs in 2 mL of sterile saline solution. To disperse clumps of 
bacteria, cells were either passed 10 times through a 27-gauge needle or briefly sonicated. 
Percentage viability of MAP in the inocula was measured by use of a commercial bacterial 
viability kitc (following the manufacturer's directions); the mean ± SEM percentage of live 
MAP used for inoculation was 80 ± 2%. For 1 group of 7 calves in which lymph nodes were 
excised at PID 60 and in which proliferation was evaluated after 7 days, aliquots of 100 mg 
(wet weight) of MAP were frozen at -80°C until use, thawed, and resuspended by gentle 
sonication prior to inoculation. One aliquot of this frozen inoculum was thawed and plated in 
10-fold dilutions onto 7H10 agar plates; this inoculum contained 4.98 X 10* CFUs/2 mL. 
Control calves were inoculated with 2 mL of sterile saline solution and vaccine-inoculated 
calves received a single dose of the killed bacterin (the amount commercially labeled for 
vaccination of 1 animal) at each of the 2 inoculation sites. The skin at the site of inoculation 
in each calf was shaved to mark the site for later excision. 
Collection of lymph nodes and inoculation sites-— Superficial cervical lymph 
nodes were surgically excised following a previously described procedure.12 In some 
instances, the right superficial cervical lymph node was excised from a calf immediately 
prior to inoculation of the left cervical area so that pre-inoculation tissues were available for 
comparison. Calves were sedated with xylazine (0.044 mg/kg, IV) and anesthetized with 
ketamine (10 mg/kg, IM). A cutaneous incision was made over the lymph node; the 
subcutaneous tissues were bluntly dissected to expose the underlying brachiocephalics 
muscle, which was longitudinally separated by blunt dissection. The lymph node was 
dissected from its connective tissue attachments and excised, and the skin was closed by use 
of nylon sutures. Portions of the excised node were cultured for MAP or stored in ice-cold 
tissue culture medium for later isolation of lymph node mononuclear cells (LNMCs), a 
suspension containing lymphocytes and monocytes. The skin and subcutaneous tissue at the 
inoculation site were excised and divided in half; specimens were preserved in neutral-
buffered 10% formalin for routine histologic evaluation and in embedding compound*1 in 
liquid nitrogen for immunohistochemical analyses. For confirmation of DTH results, 
measured indurations were surgically excised and placed immediately in neutral-buffered 
10% formalin for routine histologic evaluation by use of paraffin embedment techniques. 
Bacteriologic analysis—In 1 group of calves (including 6 calves inoculated with 
MAP, 2 calves inoculated with saline solution, and 3 calves inoculated with the vaccine), 
biopsy specimens of lymph nodes were obtained for histologic evaluation and culture for 
MAP at PID 7,21, or 60; calves were then allowed to continue in the study until PID 150, at 
which time they were euthanatized. From each of these calves, samples of peripheral blood 
were collected and cultured for MAP at PID 0 (pre-inoculation), 1,3, and 7 and samples of 
feces were collected and cultured for MAP at PID 0,1, 3,7,14, 30, 60,90,120, and 150. In 
another group of calves (including 12 calves inoculated with MAP and 12 calves inoculated 
with saline solution), specimens of feces and lymph nodes were cultured for MAP at the time 
of euthanasia and lymph node removal (ie, at PID 7 for 6 calves, at PID 14 for 6 calves, and 
PID 60 for 12 calves). Peripheral blood samples were collected from the first group of 11 
calves and cultured for MAP following previously described methods13 with modifications. 
Ten milliliters of 7H9 broth supplemented with mycobactin J was added to 1 mL of 
heparinized whole blood from each calf. Following a 2-week incubation period, 100 piL of 
each sample was plated in duplicate or triplicate onto Middlebrook 7H10 agar. For detection 
of MAP in feces, 1 g of fresh feces was placed in 35 mL of sterile water and vortexed for 1 
minute; particulates were allowed to settle for 30 minutes. Five milliliters of supernatant was 
withdrawn and added to 25 mL of 0.9% 
1 -hexadecylpyridium chloride (HPC).e After overnight incubation (approximately 18 
hours) in HPC, 200 ]*L of the sediment was inoculated onto Herrold's egg yolk medium 
slants with and without mycobactin J. To culture MAP from lymph nodes, 200 mg of tissue 
from each node was placed in 5 mL of 0.75% HPC and minced with a tissue homogenizer. 
Samples were decanted into sterile tubes and incubated for approximately 18 hours; 200 piL 
of the sediment was then plated onto slants of Herrold's egg yolk medium with and without 
mycobactin J. For all cultures, samples were incubated at 37°C and the presence or absence 
of colonies confirmed after 16 weeks. 
Immunohistochemical analyses of inoculation site tissues— Frozen tissue sections 
were stored at -80°C until processed immunohistochemically. Tissues were sectioned at 4 
yim, adhered to the slides with a tape transfer system', and fixed in 100% ethanol for 8 
minutes at -80°C. The monoclonal antibodies used included mouse anti-bovine CD3 (IgGl 
clone MM1A, diluted 1:50),8 mouse anti-bovine CD4 (IgG2a clone IL-A11, diluted 1:50),8 
and mouse anti-bovine yb TCR (IgG2b clone GB21A, diluted 1:10,000).8 Normal mouse 
IgGh was used for negative controls. Nonspecific antibody binding was blocked with 20% 
normal swine serum for 30 minutes. Primary antibodies were diluted in antibody diluent' 
containing 5% normal goat serum and 5% normal swine serum for 1 hour at 22 C. Slides 
were washed in a washing buffer" and endogenous peroxidase was blocked with 0.3% 
hydrogen peroxide in methanol for 30 minutes at 22 C. After washing, nonspecific protein 
interactions were again blocked by addition of 5% IgG- and protease-free bovine serum 
albumink for 10 minutes, and sections were incubated for 40 minutes at 22 C with 
biotinylated goat anti-mouse IgG.1 Streptavidin-conjugated horseradish peroxidase"1 was 
incubated with the sections for 35 minutes at 22 C. Antibody binding was detected with a 
red chromogen" followed by counterstaining with hematoxylin. Sections were dehydrated 
through graded alcohols, placed in xylene, and mounted.0 
Isolation of LNMCs— Lymph nodes were transported to the laboratory in cold 
RPMI 1640 medium supplemented with 10% fetal bovine serum, penicillin G (100 U/mL), 
streptomycin (100 /ig/mL), amphotericin B (250 ng/mL), 0.5 mM 2-mercaptoethanol, and 2 
mM L-glutamine (complete medium). To obtain a single-cell suspension of LNMCs, 
superficial cervical lymph nodes were thinly sectioned on a sterile plate, finely minced by 
use of a sterile scalpel blade, and washed from the plate with fresh complete medium through 
a 10-pim nylon filter.p Resulting suspensions were centrifuged over a density gradient"1 to 
separate mononuclear cells from cell debris. Mononuclear cells were washed in serum-free 
medium or PBS solution and cell viability determined via trypan blue exclusion. 
Evaluation of LNMCs via a cell proliferation assay and surface staining—The 
LNMCs were stained with a membrane dye (PKH67e) used to detect cell proliferation 
(following the manufacturer's directions). In the cell proliferation assay, cells are stained 
with PKH67 prior to placing them in culture and as cells divide, each daughter cell 
population retains half the fluorescence of the parent population because the membrane dye 
is divided equally between the daughter cells. The loss of PKH67 fluorescence in the culture 
sample is assessed to determine cell proliferation. The PKH67-stained LNMCs were plated 
in 96-well plates at a density of 2 X 105 cells (in 100 piL of complete medium)/well. Cultures 
were then stimulated via addition of 100 jiL of complete medium containing MAP-PPD11 
(final concentration, 6.25 to 10 /ig/mL) or concanavalin A (final concentration, 5 ^g/mL), or 
remained unstimulated via addition of medium only. Cultures were incubated for 4 or 7 days 
at 37°C in 5% carbon dioxide. 
After culture, LNMCs were collected and immediately processed for flow cytometry; 
culture supernatants were cleared of cells and stored at -80°C for subsequent determination 
of soluble IFN-Y concentrations. Cultured LNMCs were stained for cell surface markers by 
use of a previously described protocol.14 The monoclonal antibodies used included mouse 
anti-bovine CD4 (IgG2a clone IL-A11),8 mouse anti-yô TCR (IgG2b clone GB21 A),8 and 
mouse anti-bovine CD8 (IgG2a clone CC63).r Isotype-matched irrelevant control antibodies 
(mouse IgG2a and IgG2b)swere included in parallel samples as controls for nonspecific 
antibody labeling. Primary antibodies were diluted in PBS solution containing 1% fetal 
bovine serum and 0.1% sodium azide (fluorescence-activated cell sorting buffer). Cultures 
were incubated with primary antibody against surface antigens for 15 minutes at 4°C in 
fluorescence-activated cell sorting buffer. Primary antibodies were detected with 
phycoerythrin-conjugated rat anti-mouse IgGs or anti-IgG2a/2b-biotins and streptavidin-
phycoerythrin-cy5 conjugate.5 Samples were immediately analyzed by use of a flow 
cytometer' or processed for intracellular labeling of IFN-y. Lymphocytes were electronically 
gated within each sample based on forward and side scatter properties (to determine total 
LNMC proliferation); within this gated population, cells were additionally gated on surface 
marker expression (for individual subset proliferation). To calculate antigen-specific 
proliferation, the number of cells dividing (1 or more divisions) in unstimulated wells was 
subtracted from the number of cells dividing in PPD-stimulated wells and was reported as 
proliferation per 10,000 cells.15 
Intracellular labeling of IFN-y for flow cytometry—After surface labeling, 
intracellular IFN-y was detected in LNMC cultures. Prior to staining, phorbol 12-myristate 
13-acetatee (final concentration, 50 ng/mL), ionomycinp (final concentration, 1 jig/mL), and 
brefeldin Ae (final concentration, 10 //g/mL) were added to the culture wells and cultures 
were incubated for an additional 4 hours at 37 °C, as previously described for bovine cells.16 
Washed cells were fixed in 2% paraformaldehyde for 20 minutes at 4°C. The cell 
membranes were then made permeable (permeabilization) in buffer containing 0.1% saponin, 
0.1% sodium azide, and 1% fetal bovine serum (saponin buffer). Fixed and permeabilized 
cells were incubated for 30 minutes at 4°C with mouse anti-bovine IFN-y (IgGl clone 
MCA1783)r diluted in saponin buffer. Parallel wells were incubated with mouse IgGl 
isotype-matched control antibody8 diluted in saponin buffer. The cells were washed in 
saponin buffer and incubated with phycoerythrin-conjugated rat anti-mouse IgGl (X56)s for 
30 minutes at 4°C. Cells were washed in saponin buffer, resuspended in PBS solution, and 
either stored at 4°C in the dark for approximately 18 hours or immediately analyzed via flow 
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cytometry.' Forward and side scatter plots were used to electronically gate live lymphocytes, 
and fluorescence data was collected for at least 10,000 live events/sample. To calculate 
antigen-specific IFN-y production, the number of cells positive for IFN-y expression in 
unstimulated wells was subtracted from the number of cells expressing IFN-y in PPD-
stimulated wells and was reported as the number of IFN-y-producing cells per 10,000 cells. 
Evaluation of bovine IFN-y concentration via ELISA—In culture supematants, 
IFN-y concentration was quantified by use of a commercial ELISA kit" for bovine IFN-y 
(following the manufacturer's directions). To standardize the measurement of IFN-y 
concentration across samples, 2-fold dilutions of recombinant bovine IFN-y'were assayed in 
parallel with test samples during each run. The limit of detection for this assay was 0.078 
ng/mL. 
Data analyses— Cell proliferation data" and intracellular IFN-y production™ were 
analyzed by use of commercially available flow cytometry software. Because the data were 
not normally distributed and log transformation did not normalize the distribution, non-
parametric statistical analyses were used. The DTH response, LNMC proliferation, and IFN-
y production data were compared between MAP-inoculated, control, and vaccine-inoculated 
groups with Wilcoxon and Kruskal-Wallis rank sums tests by use of a statistical analysis 
software package." Numerical data are expressed as the mean ± SEM. Results were 
considered significant at a value of P < 0.05. 
Results 
Clinical assessment following inoculation—Physical examinations were performed 
on all animals prior to entry into the study, and all calves included in the study were 
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clinically healthy at the start of the experiments. There were no significant differences in 
mean rectal temperatures among groups of calves prior to inoculation (control group, 38.7 ± 
0.1 C; MAP-inoculated group, 38.8 ± 0.1 C; and vaccine-inoculated group, 38.6 ± 0.2 C). 
There were no significant increases in mean rectal temperatures in any group at the time 
points evaluated (PID 1,3,7,14, and 60). On the basis of findings of additional physical 
examinations, calves remained clinically healthy throughout the study. Palpable swellings 
were minimal or absent at sites of inoculation with MAP or saline solution; in the 3 vaccine-
inoculated calves that were allowed to progress to PID 150, firm, nodular, cutaneous 
swellings (3 to 8 cm in diameter) formed at the sites of inoculation which persisted through 
the end of the study. At necropsy (ie, at PID 60 to 63 for 19 calves and PID 150 for 6 calves), 
MAP-inoculated calves lacked gross lesions associated with experimental treatment. 
Mycobacterium avium subsp paratuberculosis was not cultured from samples of peripheral 
blood obtained from MAP-inoculated (n = 6), saline solution-inoculated (2), and vaccine-
inoculated calves (3) before inoculation (PID 0) and at PID 1,3, and 7. Mycobacterium 
avium subsp paratuberculosis was not cultured from feces of any calf (MAP-inoculated 
calves, n = 18; saline solution-inoculated calves, 14; and vaccine-inoculated calves, 3) at any 
time point. At PID 7, MAP was recovered from the superficial cervical lymph node of 1 
MAP-inoculated calf. Gross enteric lesions of paratuberculosis were absent from all of the 
calves at necropsy. 
Subcutaneous granuloma formation—Histologic examination of tissues from the 
inoculation sites revealed mild granulomatous dermatitis and panniculitis at the site of SC 
inoculation in MAP-inoculated calves, whereas tissues from the inoculation sites in control 
calves were without lesions (Figure 1). Among MAP-inoculated calves, there was 
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infiltration of inoculation sites at PID 7 by large numbers of epithelioid macrophages, 
lymphocytes, neutrophils, and occasional multinucleated giant cells. A few acid-fast bacilli 
were present within cells that were morphologically consistent with macrophages. By PID 
14 and continuing through PID 60, inflammatory infiltrates became organized and were 
characterized as lymphocytic and granulomatous inflammation containing central clusters of 
epithelioid macrophages surrounded by and intermixed with dense sheets of lymphocytes. A 
few acid-fast bacilli were present within macrophages in a few lesions at PID 60. Similar to 
the granulomatous inflammation within the ileum that is characteristic of paratuberculosis in 
cattle,2 this granulomatous inflammation was non-encapsulated and non-caseating. In 
contrast, tissues from the inoculation sites of vaccine-inoculated calves had more severe 
histologic changes; there was marked expansion of the deep dermis and subcutis with 
multifocal to coalescing granulomas composed of central areas of necrosis surrounded by 
sheets of lymphocytes, plasma cells, macrophages, and neutrophils, which were, in turn, 
surrounded by dense fibrous connective tissue (Figure 2). 
Immunohistochemical analysis of tissues from inoculation sites— 
Immunohistochemical analysis of skin from inoculation sites was performed to detect T cell 
subsets within the inflammatory infiltrates induced by MAP inoculation. In MAP-inoculated 
calves, CD3+ cells were a prominent cellular component of the subcutaneous inflammation; 
among these CD3+ cells, CD4+ and yà TCR+ T cells were prominent subsets (Figures 3 and 
4). Immunohistochemical analysis for CD8+ T cells was not performed. 
Within skin sections from both MAP- and saline solution-inoculated calves, yb TCR+ 
T cells were detected within the superficial dermis but were absent from the epidermis, 
which is consistent with results of other investigations in cattle17,18; however, this finding is in 
contrast to that in mice, in which cutaneous yô TCR+ T cells are found in the epidermis.19 
Superficial dermal yô TCR+ T cells were frequently perivascular in location and outlined the 
course of small dermal blood vessels. There was no subjective relationship between 
treatment (inoculation with MAP or saline solution) or length of time since inoculation and 
the numbers or presence of superficial perivascular yô TCR+ T cells. 
Results of DTH testing—Delayed-type hypersensitivity responses to the MAP-PPD 
preparation used in our in vitro assays11 were evaluated in calves at either PID 60 or PID 90. 
Prior to and 72 hours after ID injection of PPD, skin thickness at the injection site was 
measured. In MAP-inoculated calves (n = 13), there was a significant (P = 0.01) increase in 
DTH reaction site thickness (mean net increase, 3.7 ± 0.7 mm), compared with the increase 
in thickness in the control calves (n = 6; mean net increase, 0.8 ± 0.5 mm). Similarly, there 
was a significant (P = 0.03) increase in skin thickness in vaccine-inoculated calves (n = 3; 
mean net increase, 6.2 ± 1.5 mm), compared with the increase in thickness in the control 
calves. The increases in DTH reaction site thickness in MAP- and vaccine-inoculated calves 
were not significantly different. Histologic examination of the DTH reaction sites confirmed 
the results of the skin thickness measurements and was consistent with DTH responses in 
cattle sensitized to mycobacteria.17 The increased thickness in these areas was a result of 
variable amounts of edema and fibrin accumulation that separated collagen fibers of the 
dermis; small dermal blood vessels were generally surrounded by several layers of 
lymphocytes and macrophages. 
Antigen-specific T cell proliferation— Lymph nodes were processed to obtain 
viable LNMC suspensions before inoculation (PID 0, n = 14), at PID 14 (5), and at PID 60 
(21). The LNMCs were then cultured in the presence or absence of PPD for 4 or 7 days, and 
cells were labeled for flow cytometric detection of cell surface antigens. At PID 0 and PID 
14 in the cultures of LNMCs stimulated with PPD for 4 days, no significant differences in 
antigen-specific proliferation were detected among either total LNMC or among individual 
subsets. At PID 60 in the cultures of LNMCs stimulated with PPD for 4 days, antigen-
specific LNMC proliferation was increased (P = 0.02) in MAP-inoculated calves (494 ± 157 
cells; n = 6), compared with proliferation in the saline solution-inoculated calves (10 ± 10 
cells; 6). There were no significant differences in proliferation of individual subsets after 
PPD stimulation between MAP-inoculated and control calves. In cultures of LNMCs 
stimulated with concanavalin A for 5 days, mean proliferation of total LNMCs was increased 
(P <0.01) in calves inoculated with MAP (3,552 ± 295 cells) and in calves inoculated with 
saline solution (5,176 ± 937 cells), compared with mean proliferation of total LNMCs in 
unstimulated cultures. There was no significant difference in mean proliferation of total 
LNMCs after 5 days of concanavalin A stimulation between MAP-inoculated and control 
calves. 
To increase the sensitivity of the proliferation assay, LNMC cultures from additional 
calves (9 MAP-inoculated and 6 control calves) were evaluated after 7 days of stimulation. 
Cultures from MAP-inoculated calves obtained at PID 60 and stimulated for 7 days had a 
significant (P = 0.05) increase in mean proliferation of total LNMCs, compared with 
proliferation in cultures from the calves inoculated with saline solution obtained at PID 60 
and stimulated for 7 days (Figure 5). Although the findings were not significantly different 
from those in the calves inoculated with saline solution, enhanced antigen-specific 
proliferation of CD4+ (P = 0.22), CD8+ (P = 0.11), and y& TCR+ T cells (P = 0.12) was also 
detected in cultures from MAP-inoculated calves obtained at PID 60 and stimulated for 7 
days. Compared with calves inoculated with saline solution or MAP, vaccine-inoculated 
calves (n = 2) had markedly increased LNMC proliferation (2,030 ± 565 cells) at PID 60, 
with predominant proliferation of CD4+ cells (1,841 ± 1,075 cells). Concanavalin A 
treatment of LNMCs from all calves induced marked lymphocyte proliferation. 
Production of IFN-y—The IFN-y production by LNMCs cultured for 4 or 7 days 
with and without PPD was assessed via flow cytometry. At PID 14 and PID 60, MAP-
inoculated calves had detectable antigen-specific IFN-y-producing cells within their 
superficial cervical lymph nodes after 4-day culture, compared with data for calves 
inoculated with saline solution but these findings were not significant, (Table 1). 
Interestingly, comparison of the individual subsets with the total IFN-y+ LNMC at each time 
point in the calves inoculated with MAP or saline solution revealed that most of the 
detectible IFN-y+ cells did not express CD4, CD8, or the yô TCR. In contrast, after 7 days of 
stimulation, the LNMCs obtained from calves inoculated with the commercial vaccine (n = 
2) had substantial numbers of antigen-specific IFN-y* LNMCs (5,535 ± 752 cells) at PID 60, 
and most of these cells were CD4+ (4,862 ± 1,614 cells). The number of IFN-y* LNMCs 
increased in all calves as a result of concanavalin A stimulation; however, there were no 
significant differences between groups of calves at each time point. 
Supernatants from 7-day cultures of lymph nodes obtained at PID 60 were tested for 
IFN-y by use of a commercially available ELISA. Antigen-specific IFN-y production was 
calculated as the amount of IFN-y produced in PPD-stimulated cultures minus the amount of 
IFN-y produced in unstimulated cultures. Compared with antigen-specific IFN-y production 
in calves inoculated with saline solution (0.12 ± 0.12 ng/mL), production in MAP-inoculated 
calves was slightly higher (1.29 ± 1.00 ng/mL) but the difference between these groups was 
not significant because of the large amount of variability among the MAP-inoculated calves. 
Compared with the production in culture supematants from unstimulated cultures, cultures 
from calves in both those treatment groups had increased (P < 0.01) IFN-y production after 
stimulation with concanavalin A for 7 days (3.48 ± 1.03 ng/mL in calves inoculated with 
MAP and 2.38 ± 1.07 ng/mL in calves inoculated with saline solution-inoculated calves). 
There was no significant difference in IFN-y production after 7 days of concanavalin A 
stimulation between MAP-inoculated and control calves. 
Discussion 
In the present study, 4-week-old calves were inoculated SC with live MAP, sterile 
saline solution, or a commercial paratuberculosis vaccine to evaluate histopathologic changes 
within the inoculation sites and assess the development of T cell responses. No clinical 
abnormalities were detected in any of the calves as a result of inoculation. Mycobacterium 
avium subsp paratuberculosis was not cultured from feces collected from calves before 
inoculation or at any time point after inoculation through PID 150 (the latest time of 
necropsy at which 11 inoculated calves were examined postmortem). Enteric lesions of 
paratuberculosis were lacking in all calves at necropsy. 
In a previous study20 to evaluate the potential infectivity of MAP when used as a live 
vaccine, 3-week-old calves were inoculated SC in the cervical region and intestinal and other 
tissues were evaluated for MAP infection. Mycobacterium avium subsp paratuberculosis 
was cultured from the feces of 5 of those 7 inoculated calves by PID 150; similarly, MAP 
was cultured from specimens of intestine and mesenteric lymph nodes in 5 of 7 calves at 
necropsy. In the study of this report, MAP was not cultured from samples of blood or feces 
at any time point; this contradictory finding may be a result of differences in virulence 
between bacterial strains used in the 2 studies. Although the strain used by the other 
investigators was not described in detail,20,21 it was apparently virulent in cattle, whereas the 
strain in our experiments was the laboratory-adapted type strain. In the previous study,20 the 
potential infectivity of MAP by the SC route of infection was evaluated; in our study, we 
intended to administer a dose of MAP that would be sufficient to elicit an immune response, 
and the bacterial inoculum used resulted in a strong DTH response in calves by PID 60. In 
the MAP-inoculated calves in the present study, organisms could persist within inoculation 
sites through PID 60 (the latest time point at which tissue from the inoculation sites was 
collected). However, there was no evidence of enteric infection at PID 150; whether the 
MAP-inoculated calves in our study would have progressed to develop enteric infection 
beyond PID 150 is unknown. 
Clearly, the organization of lymphoid tissue and the dose of organisms received differ 
between sites of natural enteric infection and experimental SC inoculation. Components of 
the mucosal immune system include gut-associated lymphoid tissue, lymphocytes within the 
epithelium and lamina propria, M cells, and local IgA production.22 Lymphoid tissue near 
sites of SC inoculation is restricted to the draining lymph node. The dose of organisms 
received though skin or mucosae would likely be different; at SC inoculation sites, a large 
single dose of organisms is usually received, whereas at mucosal sites, single or multiple 
smaller doses of organisms are received. Thus, infection induced experimentally via SC 
inoculation may not reflect the immunopathogenesis of natural infection. Despite these 
differences, the initiation of the immune response may share some similarities in both 
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systems. We hypothesize that, as in cutaneous infection with Leishmania organisms,23 MAP 
is engulfed by dendritic cells that process the bacteria and migrate to regional lymph nodes 
for presentation of antigen to antigen-specific T cells, thereby initiating the adaptive immune 
response. In the intestinal tract, MAP is taken up by intestinal M cells and passed to 
macrophages within and beneath the dome epithelium.24 The role of dendritic cells in the 
initiation of the immune response to MAP in the intestinal tract has not been reported; 
however, it has recently been shown that after passing through M cells, enteric bacteria are 
engulfed by dendritic cells.25 These dendritic cells migrate to the mesenteric lymph node and 
induce specific IgA production.25 Thus, dendritic cells may play a central role in initiating the 
immune response in experimentally induced infection via the SC route and in naturally 
occurring infection via the enteric route. 
Early lesions of paratuberculosis are thought to form in small focal areas, consisting 
of epithelioid macrophages and multinucleated giant cells in the tips of intestinal villi and in 
the sinuses of mesenteric lymph nodes.2 At the time of clinical disease, focally extensive 
regions of intestinal lamina propria and submucosa and entire mesenteric lymph nodes are 
filled with macrophages, multinucleated giant cells, and lymphocytes1 (forming non-
caseating granulomas).2 Lesions induced within SC inoculation sites may be similar 
morphologically to the granulomatous inflammation described in the early stages of naturally 
occurring MAP infection in cattle. In our study, calves inoculated with live MAP developed 
paucibacillary granulomatous dermatitis and panniculitis within the inoculation site; no 
inflammation was observed in inoculation sites from control calves. At PID 60, lesions in 
MAP-inoculated calves consisted of epithelioid macrophages and multinucleated giant cells 
intermixed with large numbers of lymphocytes. 
The response by calves to the commercial paratuberculosis vaccine is consistent with 
a strong Thl response. Similar to the tuberculoid granulomas typical of M bovis infection,26 
vaccine-inoculated calves developed SC granulomas that were encapsulated by fibrous 
connective tissue and contained central areas of necrosis. Consistent with Thl polarization in 
this type of granuloma, CD4+ T cells, IFN-y, and interleukin-12 are all required for the 
formation of necrotic centers in M avium-mduced granulomas in mice.27 In the vaccine-
inoculated calves of the present study, cells from the draining lymph node had strong Thl 
polarization; there was marked antigen-specific CD4+ T cell proliferation and substantial 
antigen-specific IFN-y production. The commercial vaccine contains an oil adjuvant,28 which 
likely also had a role in inducing the marked inflammation detected in vaccine-inoculated 
calves. 
In contrast to the granulomas in the vaccine-inoculated calves, a lack of Thl 
polarization may be responsible for the less distinctly organized granulomatous inflammation 
without central necrosis and peripheral fibrosis observed in MAP-inoculated calves. 
Numerous CD4+ and yô TCR+ T cells infiltrate into the site of local MAP infection, but 
whether these infiltrating T cells are polarized towards a Thl response is unknown. At PID 
60 in the MAP-inoculated calves, antigen-specific T cells were present within the lymph 
node draining the site of MAP inoculation; however, because of the variability in 
proliferation of individual lymphocyte subsets among calves, no significant increases in 
antigen-specific proliferation were detected among the CD4\ CD8+, and yô TCR+ T cell 
subsets, although CD4+ T cell proliferation appeared to predominate. The weak antigen-
specific IFN-y production from the draining lymph nodes of MAP-inoculated calves at PID 
60 indicates that these T cells may not mature into functional IFN-y-secreting T cells. 
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Interestingly, most of the IFN-y producing cells did not take up label for CD4, CD8, or the yô 
TCR. Other IFN-y-producing cells which might contribute to the IFN-y production in this 
system could include natural killer cells29 and natural killer T cells.2930 Specific markers to 
label these cell populations are not currently available for bovine cells, so the hypothesis that 
these cells are involved in IFN-y production in the recall response to MAP antigens awaits 
future investigation. 
The data obtained in the present study have indicated that SC inoculation of calves 
with live MAP can induce SC granulomatous inflammation with infiltration of CD4+ and yô 
TCR+ T cells into those lesions. Within the draining lymph node, moderate antigen-specific 
expansion of MAP-specific T cells was detected without significant production of antigen-
specific IFN-y; however, MAP-inoculated calves developed a positive DTH response by PID 
60, which suggests a strong peripheral Thl response. In our opinion, this SC infection model 
could be used to further define the functional roles of T cell subsets during MAP infection. 
"Mycopar Mycobacterium paratuberculosis bacterin, SOLVAY Animal Health, Mendota 
Heights, Minn. 
""Generous donation of Dr. Charles Thoen, Department of Microbiology and Preventive 
Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa. 
^LIVE/DEAD BacLight bacterial viability kit, Molecular Probes, Eugene, Ore. 
dTissue-Tek OCT compound, Sakura Finetek USA Inc, Torrance, Calif. 
"Sigma, St Louis, Mo. 
fCryoJane Tape Transfer System, Instrumedics Inc, Hackensack, NY. 
8VMRD Inc, Pullman, Wash. 
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"Vector Laboratories, Burlingame, Calif. 
'Common Antibody Diluent, BioGenex, San Ramon, Calif. 
jOptiMax™ Wash Buffer, BioGenex, San Ramon, Calif. 
kJackson ImmunoResearch, West Grove, Pa. 
'Kirkegaard and Perry Laboratories, Gaithersburg, Md. 
mBioGenex, San Ramon, Calif. 
"NovaRED, Vector Laboratories, Burlingame, Calif. 
°Permount, Fisher Scientific, Pittsburg, Pa. 
pFisher Scientific, Pittsburg, Pa. 
"Histopaque, Sigma, St Louis, Mo. 
rSerotec, Raleigh, NC 
TharMingen, San Diego, Calif. 
"FACScan, Becton-Dickinson, San Jose, Calif. 
"BOVIGAM, Biocor Animal Health, Omaha, Neb. 
vModFit LT, Verity Software House, Topsham, Me. 
"CellQuest, Becton-Dickinson, San Jose, Calif. 
XJMP 5.1, SAS Institute Inc, Cary, NC 
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Figure 1—Photomicrographs of skin tissue from a site of subcutaneous (SC) inoculation 
with Mycobacterium avium subsp paratuberculosis (MAP) in a calf (obtained at post-
inoculation day [PID] 60). A—Notice the focally extensive accumulation of large numbers of 
lymphocytes and lesser numbers of macrophages within the deep dermis. B—At higher 
magnification, multinucleated giant cells (arrows) surrounded by lymphocytes (arrowheads) 
are evident within the granulomatous inflammation. H&E stain. In panel A, bar = 100 jxm; in 
panel B, bar = 10 pim. 
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Figure 2—Photomicrographs of skin tissue from a site of SC inoculation with a 
commercially available paratuberculosis vaccine (MAP bacterin) in a calf (obtained at PID 
150). In the deep dermis, notice that the granuloma is composed of a central area of necrosis 
(N) that is surrounded by numerous cells (*) and contained within a fibrous capsule (arrows); 
the cells surrounding the area of necrosis include lymphocytes, plasma cells, macrophages, 
and occasional neutrophils. H&E stain. Bar = 100 pim. 
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Figure 3—Photomicrograph of skin tissue from a site of SC inoculation with MAP in à calf 
(obtained at PID 60) after immunohistochemical analysis to detect CD4+ T cells by use of a 
biotin-streptavidin-peroxidase technique and hematoxylin counterstain. Notice that labeled 
CD4+ T cells (arrows) have a dark precipitate around their cytoplasmic edges and are 
scattered within an area of granulomatous inflammation. Bar = 50 iim. 
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Figure 4—Photomicrograph of skin tissue from a site of SC inoculation with MAP in a calf 
(obtained at PID 14) after immunohistochemical analysis to detect yb TCR+ T cells by use of 
a biotin-streptavidin-peroxidase technique and hematoxylin counterstain. Notice the 
lymphoid accumulation embedded within panniculus muscle (muscle fibers not visible in this 
section) containing scattered yb T cell receptor (TCR)+ T cells (arrows). Bar = 50 /im. 
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Figure 5—Results of antigen-specific lymphocyte proliferation assays in cultures (stimulated 
for 7 days with purified protein derivative [PPD] of MAP) of lymph node mononuclear cells 
(LNMCs) obtained from superficial cervical lymph nodes that drained sites of SC inoculation 
in 15 calves, 6 of which were treated with saline solution (white bars) and 9 of which were 
treated with MAP (black bars). The LMNCs were collected at PID 60. Assessments were 
made of total lymphocyte proliferation and proliferation of CD4+, CD8+, and yô TCR+ T 
cells. Antigen-specific proliferation was calculated by subtracting the number of cells (per 
10,000 LNMCs) proliferating in unstimulated cultures from the number of cells (per 10,000 
LNMC) proliferating in PPD-stimulated cultures. * Value in the MAP-inoculated calves was 
significantly (P = 0.05) greater than that of the control calves. 
PID 
stimulated 
in vitro inoculum 
antigen-specific IFN-y production (per 10,000 LNMC) 
total CD4+ CD8+ vôTCR+ 
Con A 
total! 
ot 4 saline (n=7) 402+124 9+5 ÎO3+53 4+3 l828+28! 
M. a. ptb (n=6) 495±259 20+17 84+41 6+6 1639+296 
14 4 saline (n=2) 267±97 0±0 9+9 4O+4O 1189+158 
M. a. ptb (n=3) 800+131 28+28 4Î7+2Î4 ÎO8+68 !l89+85 
60 4 saline (n=5) 250±116 15+10 89+42 25±15 990+75 
M. a. ptb (n=6) 776±337 6+3 Î3Î+48 57±30 Î339+278 
60 7 saline (n=2) 90±90 37 (n=l) 31+19 22±22 1810+580 
M. a. ptb (n=4) 1205+412 544+4!8 ÎO8+3Î 227+97 253O+369 
vaccine (n=2) 5535+752 486Î+Î6Î4 141+88 0+0 38Î5+Î255 
t Denotes preinoculation lymph nodes. Calves are grouped according to future treatment. 
$ Total IFN-y* cells among con A-stimulated LNMC (per 10,000 LNMC). 
Table 1—Mean ± SEM antigen-specific interferon (IFN)-y production in cultures (stimulated for 4 or 7 days with purified protein 
derivative [PPD] of MAP or concanavalin A) of lymph node mononuclear cells (LNMCs) obtained from superficial cervical 
lymph nodes that drained sites of SC inoculation in calves that were treated with saline solution or MAP. The LMNCs were 
collected at post-inoculation day (PID) 0,14, and 60. Antigen-specific IFN-y production was assessed for total lymphocyte 
population (PPD and concanavalin A stimulation) and the CD4+, CD8+, and yô TCR+ T cell subsets (PPD stimulation). For PPD-
stimulated LNMC, antigen-specific IFN-y was calculated as the number of cells (per 10,000 LNMCs) producing IFN-y in PPD-
stimulated cultures minus the number of cells (per 10,000 LNMCs) producing IFN-y in unstimulated cultures. Values for con A-
stimulated LNMC are equal to the total number of LNMC producing IFN-y in con A-stimulated cultures. 
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CHAPTER 3: THE IMMUNE RESPONSE IN THE LYMPH NODE DRAINING THE 
SITE OF MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS INFECTION 
IS IMPAIRED IN COMPARISON TO THE CENTRAL IMMUNE RESPONSE. 
A paper to be submitted to Infection and Immunity 
Frank J. Simutis, Jesse M. Hostetter, and Douglas E. Jones 
Abstract 
The immune response in draining lymph nodes, peripheral blood, and the spleen in 
cattle inoculated with Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis) 
was assessed in a subcutaneous challenge system. In the first experiment, eight four-week-
old male Holstein calves were inoculated subcutaneously with live M. paratuberculosis in 
the left cervical region in an area draining into the left superficial cervical lymph node. 
Lymphocytes were isolated at post-inoculation day (PID) 60 from superficial cervical lymph 
node, peripheral blood, and spleen and tested for antigen-specific proliferation and IFN-y 
production. M. paratuberculosis-purified protein derivative (PPD)-stimulated lymphocytes 
from each site proliferated more strongly than unstimulated lymphocytes from the same site. 
There was a statistically significant increase in antigen-induced proliferation from splenic 
lymphocytes compared to antigen-stimulated lymphocytes from the lymph node draining the 
site of inoculation. There were significantly increased amounts of interferon (IFN)-y 
produced by antigen-stimulated cultures compared to unstimulated cultures from each site, 
and a strong trend for antigen-stimulated spleen cells to produce more IFN-y than antigen-
stimulated draining lymph node cells. 5/8 calves developed a strong delayed-type 
hypersensitivity (DTH) response to PPD. The data suggests that calves develop a stronger 
central Thl response compared to the response by the lymph node draining the site of 
infection. Therefore, we tested the hypothesis that the local immune response to 
subcutaneous challenge was impaired in comparison with the central response. To test this, 
we elicited a strong systemic Thl response to M. paratuberculosis through vaccination, and 
subsequently challenged the animals subcutaneously to evaluate the response in the draining 
lymph node. At four weeks of age, three calves were vaccinated in the left cervical region 
with the commercial paratuberculosis vaccine, and three age-matched animals were left 
unvaccinated. At PID 60, all calves were challenged subcutaneously in the right cervical 
region with live M. paratuberculosis. At PID 123, animals remaining in the study were 
euthanatized, and the left and right superficial cervical lymph nodes, peripheral blood, and 
portions of the spleen were collected for lymphocyte functional analysis. Data from one 
vaccinated calf and two non-vaccinated calves were available for analysis. In the vaccinated 
calf, the lymph node draining the vaccination site as well as the spleen had large percentages 
of CD4+ IFN-y+ cells in PPD-stimulated, but not in unstimulated cultures. In contrast, the 
lymph node draining the challenge site in the vaccinated animal had few IFN-y+ cells and 
results were similar to those from the lymph nodes draining the challenge sites in non-
vaccinated calves. At PID 123, all calves had a strong DTH response. Together, these 
experiments suggest that at the site of infection, impaired antigen-presenting cell (APC) 
function induced by infection with live M. paratuberculosis may prevent appropriate 
signaling between APC and CD4+ T cells or reduce trafficking of CD4+ T cells into the 
draining lymph node and lesion site. 
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Introduction 
Paratuberculosis (Johne's disease) is a granulomatous enteritis of ruminants caused 
by infection with Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis). 
Macrophages are the host cell for M. paratuberculosis, and the pathogen has developed 
means of surviving and replicating within these phagocytes (13, 28). Animals are typically 
infected as neonates from fecal-oral transmission (7), although in utero transmission has been 
also been described (21). In most animals is it presumed that the infection is cleared (7), but 
some animals enter a long subclinical phase during which M. paratuberculosis can be 
intermittently shed in the feces (30). After several years of subclinical infection, animals 
progress to clinical disease in which there is cachexia despite normal appetite, profuse 
diarrhea with fecal shedding of organisms, hypoproteinemia, and decreased milk production 
(30). 
Data from Mycobacterium tuberculosis-infected mice indicate that CD4+ T cells and 
the production of interferon (IFN)-y are essential for protective immunity (18). After 
intratonsillar infection with M. paratuberculosis, antigen-specific CD4+ T cell proliferation 
was detected in the peripheral blood of cattle 286 days post-inoculation, with production of 
IFN-y by CD4+ T cells at 313 days post-inoculation (27), and in orally-inoculated calves, an 
antigen-specific CD4+ T cell response developed in the periphery 6 months after infection 
(16). During the subclinical phase, peripheral blood mononuclear cells (PBMC) proliferate 
vigorously and produce large amounts of IFN-y and TNF-a in response to antigenic 
stimulation (23). Despite the initial CD4+ T cell response, which limits fecal shedding of the 
pathogen to low levels, cell-mediated immunity begins to wane late in the disease (6). 
Antigen-specific lymphocyte proliferation and production of IFN-y and TNF-a declines to 
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levels elicited by PBMC of non-infected controls (23). Within the ileum and cecal lymph 
node, IFN-y mRNA expression decreases as animals transition from the subclinical to the 
clinical phase (25). 
Few studies have compared the immunologic response at the site of M. 
paratuberculosis infection with the systemic immune response. Koets, et al. compared the 
proliferative response between PBMC, mesenteric lymph node lymphocytes, and ileal lamina 
propria lymphocytes to live M. paratuberculosis and its antigens in infected cattle (15). 
Although there was no difference in proliferation to PPD or live bacteria between PBMC and 
lymphocytes from mesenteric lymph nodes in clinically-affected cattle, lamina propria 
lymphocytes had a 10-fold decrease in stimulation indices compared to PBMC (15). In 
sheep with clinical paratuberculosis, antigen-specific lymphocyte proliferation was greatest 
among PBMC, followed by mesenteric lymph node lymphocytes, with lamina propria 
lymphocytes having the lowest degree of proliferation (5). Lymphocytes from the 
mesenteric lymph node of sheep with tuberculoid lesions produced significant IFN-y in 
response to antigenic stimulation, whereas PBMC and lamina propria lymphocytes produced 
similar amounts of IFN-y as those from non-infected controls (4). These studies suggest that 
different degrees of immune responsiveness to M. paratuberculosis can occur in different 
tissues within the same animal, and that responsiveness decreases nearest the site of 
infection. 
We have previously developed an experimental system to study the development of 
antigen-specific T cells in response to infection with M. paratuberculosis (22). In this 
system, four-week-old bovine calves are inoculated subcutaneously in the cervical region 
with a single large dose of organisms, and the draining lymph node is excised at post-
97 
inoculation day (PID) 60 for analysis of lymphocyte function. Calves develop a moderate 
antigen-specific proliferative response by draining lymph node cells with little production of 
antigen-specific IFN-y (22), yet they develop a strong delayed-type hypersensitivity (DTH) 
response. Because of this strong DTH response, our hypothesis for this study was that 
central immunity, mediated by the spleen, would be more strongly Thl polarized during the 
recall response than the response by the draining lymph node. We used the subcutaneous 
infection system and collected draining lymph node, peripheral blood, and spleen to evaluate 
the immune response in these immunologic compartments. Because subcutaneously-infected 
animals have a weakly Thl polarized local response and a strong DTH response, we 
hypothesized that the immune response occurring at the site of infection was impaired 
despite the presence of systemic M. paratuberculosis-specific effector/memory CD4+ T cells. 
To test this hypothesis, we elicited strong cell-mediated immunity against M. 
paratuberculosis through vaccination, challenged calves with a subcutaneous M. 
paratuberculosis infection, and assessed the recall response in the draining lymph nodes. 
Materials and Methods 
Antibodies and antigens. To identify lymphocyte subsets, the following monoclonal 
antibodies were used: mouse anti-bovine CD4 (IL-A11, VMRD, Pullman, WA), mouse anti-
bovine yb TCR (GB21A, VMRD), mouse anti-bovine CDS (CC63, Serotec, Raleigh, NC), 
mouse anti-bovine yô TCR (GB21A, VMRD), mouse anti-bovine B cell marker (LCT2A, 
VMRD), or isotype control antibodies (IgG2a and IgG2b, Pharmingen, San Diego, CA). 
Biotinylated anti-mouse IgG2a/2b followed by streptavidin-CyChrome conjugate 
(Pharmingen) was used to label cell surface markers. Intracellular IFN-y was detected with 
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mouse anti-bovine IFN-y (MCA1783, Serotec) and phycoerythrin-conjugated rat anti-mouse 
IgGl (X56, Pharmingen). Purified protein derivative (PPD) from M. paratuberculosis strain 
19698, prepared as described (24), was a generous gift of Dr. Charles Thoen, Department of 
Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, I A. 
Animals. All animal protocols in this experiment were approved by the Iowa State 
University Committee on Animal Care. Thirteen male Holstein calves were purchased at 
three weeks of age from the Iowa State University dairy research farm in Ankeny, IA. This 
farm has had no clinical cases of paratuberculosis in the last 5 years, and fecal cultures and 
antibody ELIS As from cows with chronic diarrhea have been consistently negative for M. 
paratuberculosis infection. Calves were housed in individual concrete rooms and were fed a 
complete grain mixture and water. Calves acclimated to the facilities for one week and were 
four weeks of age at the beginning of the study. 
Bacteria and experimental infection. M. paratuberculosis strain 19698 was 
cultured in Middlebrook 7H9 broth supplemented with mycobactin J. Bacteria were 
maintained in log phase growth by weekly passage; cultures 4 weeks of age were used in 
these experiments. Aliquots for inoculation into calves containing 100 mg (wet weight) of 
M. paratuberculosis were frozen at -80° C until use, thawed, and resuspended by gentle 
sonication prior to inoculation. Previously, an aliquot of this frozen inoculum was thawed 
and plated in 10-fold dilutions onto 7H10 agar plates; 100 mg wet weight of M 
paratuberculosis contained approximately 5 x 108 colony-forming units (CFU) (22). 
Experimental design. This study was divided into two experiments. For the first 
experiment, each calf (n=8) was inoculated subcutaneously in the left cervical region with 
100 mg (wet weight) of live M. paratuberculosis in an area draining into the left superficial 
cervical lymph node (LN). At post-inoculation day (PID) 57, each calf was tested for a DTH 
response to M. paratuberculosis using PPD prepared from the 19698 type strain. Each calf 
received an intradermal injection of 0.1 mL PPD in the skin over the right side of the neck 
(the side opposite that which was inoculated with M. paratuberculosis), and skin at the site of 
PPD injection was measured before and 72 hours after injection. Venous blood was obtained 
at PID 60 by jugular venapuncture into heparin-containing tubes. At PID 60, calves were 
euthanatized with an overdose of barbiturate, and a complete necropsy was performed. The 
left prescapular LN and a small portion of the spleen were aseptically removed and 
transported separately to the laboratory in cold RPMI 1640 medium supplemented with 10% 
fetal bovine serum (FBS), penicillin G (100 U/mL), streptomycin (100 fig/mL), amphotericin 
B (250 ng/mL), 0.5 raM 2-mercaptoethanol, and 2 mM L-glutamine (complete medium). 
DTH sites were excised and placed into 10% neutral buffered formalin for paraffin 
embedment using standard techniques. 
For the second experiment, calves (n=6) were randomly allocated into two groups. 
The first group (n=3) was vaccinated at four weeks of age with the commercially-available 
vaccine for paratuberculosis (Mycopar, Solvay Animal Health, Mendota Heights, MN) in the 
left cervical region. The remaining age-matched calves (n=3) were not vaccinated. Sixty 
days after administration of the vaccine, all six calves were inoculated subcutaneously in the 
right cervical region with 100 mg (wet weight) of live M. paratuberculosis. Calves were 
tested for a DTH response at PID 120 by injection of PPD into the dermis of the right tail 
fold, and the response was measured at PID 123, at which time blood was obtained by 
venapuncture. Calves were then euthanatized, and both the left and right superficial cervical 
LN as well as a small portion of the spleen were aseptically removed and placed into separate 
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containers containing complete medium. DTH sites were excised and placed in 10% neutral 
buffered formalin and routinely processed for histopathology. 
Isolation of peripheral blood mononuclear cells, lymph node cells, and spleen 
cells. PBMC were isolated by hypotonic lysis of venous blood using standard techniques. 
To isolate lymph node mononuclear cells (LNMC), superficial cervical lymph nodes were 
thinly sectioned in a sterile plate, finely minced with a sterile scalpel blade, and washed from 
the plate with fresh complete medium through a 70-/<m nylon filter (Fisher Scientific, 
Pittsburg, PA). Resulting suspensions were centrifuged over Histopaque (Sigma, St. Louis, 
MO) to separate mononuclear cells from cell debris. Spleen cells were isolated as for the 
lymph node cells and erythrocytes were cleared by hypotonic lysis. PBMC, LNMC, and 
spleen cells were washed in PBS, counted with trypan blue, and resuspended at 2 x 107 
cells/10 mL of PBS for staining with PKH67 (see below). 
PKH67 proliferation assay. PBMC, LNMC, and spleen cells were labeled with 
PKH67 to detect cellular proliferation following the manufacturer's directions (Sigma, St. 
Louis, MO). All reactions were performed at room temperature. In brief, cells in PBS were 
pelleted by centrifugation and resuspended in 1 mL of PKH67 diluent supplied by the 
manufacturer. One mL of PKH67 dye (2 piM) was added to the cell suspension, and the cells 
were incubated with the dye for 5 minutes with frequent gentle agitation. The reaction was 
stopped by the addition of 2 mL of 1% FBS and incubated for 1 minute. Four mL of 
complete medium was added to the cell suspension and the cells were pelleted by 
centrifugation. The cells were washed twice in PBS and resuspended in complete medium to 
a concentration of 2 x 106/mL. One hundred piL of the cell suspension (2 x 105 cells) was 
plated into each well in 96-well round-bottom plates. Cells received an additional 100 |xL of 
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complete medium (unstimulated cells), 100 p,L of complete medium containing 20 [xg/mL of 
PPD (antigen-stimulated cells, 10 pig/mL final concentration), or 100 [xL of complete 
medium containing 10 jig/mL of concanavalin A (con A, positive control, 5 |xg/mL final 
concentration). Cultures were incubated at 37° C and 5% C02 for 7 days and harvested for 
flow cytometry. Cells were pelleted by centrifugation and the supematants removed for IFN-
y determination (see below). For experiment 1, cells were washed once in PBS, fixed for 20 
minutes in 4% paraformaldehyde, and immediately analyzed on a FACScan flow cytometer 
(Becton-Dickinson, San Jose, CA). For experiment 2, lymphocyte surface marker labeling 
was performed prior to fixation (see below). A live lymphocyte gate was drawn on a forward 
vs. side scatter plot using Cellquest software (Becton-Dickinson) and at least 10,000 live 
lymphocytes were assessed for PKH67 (FL1) fluorescence intensity for each sample. Using 
ModFit LT software (Verity Software House, Topsham, ME), loss of PKH67 fluorescence 
intensity was assessed to determine extent of cellular proliferation. Results were expressed 
as a proliferation index, which is a numerical value comparing the number of proliferating 
cells to the number of cells originally in the parent population; a proliferation index of 1 
indicates no proliferation. 
Measurement of IFN-y in culture supematants. IFN-y in culture supematants was 
measured using a commercial bovine IFN-y ELISA (BOVIGAM, Biocor Animal Health, 
Omaha, NE) following the manufacturer's directions. To compare the amount of IFN-y 
between samples, IFN-y was quantified by comparing the optical density of individual wells 
against a standard curve constructed with 2-fold dilutions of recombinant bovine IFN-y 
(Serotec). All samples were run in duplicate. The limit of detection for this assay was 78 
pg/mL. 
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Lymphocyte phenotype analysis. To assess the expression of common surface 
markers on lymphocytes obtained from different tissue compartments, freshly-isolated 
lymphocytes from lymph nodes draining the site of M. paratuberculosis inoculation, PBMC, 
and spleen cells were washed and aliquoted into wells of a 96-well plate at 1 x 106 cells/well. 
All steps were performed at 4°C. Cells were washed in buffer composed of PBS, 1% FBS, 
and 0.04% sodium azide (Fluorescence Activated Cell Sorting [FACS] buffer). Cells were 
resuspended in mouse anti-bovine monoclonal antibodies diluted in FACS buffer for either 
CD4, CDS, the yô TCR, or a B cell marker. Cells were washed and resuspended in FACS 
buffer containing biotinylated anti-mouse IgG2a/2b. Cells were again washed and labeled 
with streptavidin-CyChrome conjugate. Cells were fixed in 2% paraformaldehyde and 
analyzed on a FACScan flow cytometer. Live lymphocytes were electronically gated on a 
forward vs. side scatter plot, and at least 10,000 gated events per sample were counted. 
Intracellular labeling for IFN-y. In experiment 2, lymphocytes from draining 
lymph nodes, peripheral blood, and the spleen were cultured in the presence or absence of 
PPD or con A for 7 days prior to harvesting. Prior to intracellular staining, phorbol 12-
myristate 13-acetate (Sigma, final concentration, 50 ng/mL), ionomycin (Fisher, final 
concentration, 1 pig/mL), and brefeldin A (Sigma, final concentration, 10 ftg/mL) were added 
to the culture wells and cultures were incubated for 4 hours at 37°C, as previously described 
for bovine cells (8). After surface labeling for CD4 or the yô TCR as above, cells were fixed 
in 2% paraformaldehyde for 20 minutes at 4°C. The cell membranes were permeablilized in 
buffer containing 0.1% saponin, 0.1% sodium azide, and 1% FBS (saponin buffer). Fixed 
and permeabilized cells were incubated for 30 minutes at 4°C with mouse anti-bovine IFN-y 
diluted in saponin buffer. The cells were washed in saponin buffer and incubated with 
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phycoerythrin-conjugated secondary antibody for 30 minutes at 4°C. Cells were washed in 
saponin buffer, and resuspended in PBS solution for analysis by flow cytometry. Live cells 
were electronically gated, and at least 20,000 gated events were counted per sample. 
Statistical analysis. Because proliferation and IFN-y production data from 
experiment one was not normally distributed, and log transformation failed to normalize the 
distribution, non-parametric analysis was used. Antigen-stimulated and unstimulated 
cultures from each site and between sites were compared with the Wilcoxon/Kruskal-Wallis 
rank sums test using JMP 5.1 software (SAS Institute, Inc., Cary, NC). For phenotypic 
analysis of freshly-isolated cells in experiment 2, one-way ANOVA was used to compare cell 
populations within difference tissue compartments. Lymphocyte population differences 
between tissue compartments were compared with Student's t-test. Differences were 
considered significant at P<0.05. 
Results 
There are different degrees of antigen-specific lymphocyte proliferation and 
IFN-y production between the lymph node draining the site of infection and the spleen. 
Lymphocyte proliferation from M. paratuberculosis-moculated calves was detected as the 
loss of PKH67 fluorescence intensity after 7 days of culture with and without antigen. To 
quantify proliferation, software which uses an algorithm to compare actual fluorescence loss 
with expected fluorescence loss by daughter cell populations was used as described in 
Materials and Methods. For all eight calves in experiment one, the mean proliferation 
indices for PPD-stimulated lymphocyte cultures from each site were statistically increased 
(P<0.05) compared to the means for unstimulated lymphocyte cultures from each site (Fig 1). 
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There was negligible proliferation in unstimulated cultures at each site, with unstimulated 
LNMC, PBMC, and splenic lymphocytes having proliferation indices of 1.1 ± 0.0,1.4 ± 0.1, 
and 1.4 ± 0.1, respectively. PPD-stimulated lymphocyte cultures from the spleen proliferated 
more strongly than PPD-stimulated lymphocytes from the draining lymph node (P<0.05, Fig 
1). 
In all 8 calves in experiment one, there was little IFN-y production by unstimulated 
lymphocytes at each site. Antigen stimulation increased IFN-y production by cells at all sites 
in all 8 calves, and the means for IFN-y production by antigen-stimulated cells at each site 
were greater than the means for unstimulated cells at each site (Fig 2). In addition, there was 
a strong trend (P=0.07) for increased IFN-y production by PPD-stimulated spleen cells 
compared to the amount of IFN-y produced by PPD-stimulated LNMC. 
Phenotypic analysis of draining lymph node cells, PBMC, and spleen cells. To 
determine if the increased antigen-specific production of IFN-y in the spleen compared to the 
draining lymph node was the result of increased percentages of CD4+ T cells in the spleen, 
we performed phenotypic analysis of LNMC, PBMC, and splenic lymphocytes. Freshly 
isolated lymphocytes were labeled with antibodies to CD4, CDS, the yô TCR, and a bovine B 
cell marker. Table 1 shows the results of this analysis. Among the different compartments, 
draining lymph nodes had the highest percentage of CD4+ T cells and the spleen had the 
lowest percentage. CD8+ T cell percentages were decreased in the peripheral blood 
compared to the lymph node and the spleen. The draining lymph node had significantly 
fewer y ô T cells compared to the spleen and the peripheral blood. Although bovine yô T cells 
are capable of producing IFN-y in response to stimulation with mycobacteria and 
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mycobacterial antigens (26), studies have shown that there is little IFN-y produced by 
stimulated bovine yô T cells during M. paratuberculosis infection (3, 22). 
Delayed-type hypersensitivity responses. Skin thickness before injection of 0.1 mL 
of PPD and 72 hours after injection was measured to determine DTH responses. In 8 out of 
11 non-vaccinated, M. paratuberculosis-inoculated calves from both experiments, skin 
thickness at the site of injection increased ïsl.5 mm (range 1.5-5.5 mm, mean 1.9 ± 0.6 mm). 
In three calves, there was no net increase in skin thickness at the site of injection. Vaccinated 
calves had the most significant DTH responses, with skin thickness increases of up to 15 
mm. Histologic examination of the DTH reaction sites revealed a cellular infiltrate within 
the dermis in all calves with a measurable increase in skin thickness, and the presence of this 
infiltrate was consistent with DTH responses in cattle sensitized to mycobacteria (10). The 
increased thickness in DTH sites was the result of accumulations of variable numbers of 
lymphocytes and macrophages within a fibrin meshwork surrounding small blood vessels 
and infiltrating into the surrounding dermal collagen (data not shown). 
Differences in immune responses between the lymph node draining the site of 
vaccination and the lymph node draining the site of subcutaneous challenge. In 
experiment one, we found that calves inoculated subcutaneously with live M. 
paratuberculosis develop a T cell response in the spleen with significantly more robust 
antigen-specific proliferation and a trend for increased antigen-specific IFN-y compared to 
the lymph node draining the site of infection. In addition, most subcutaneously-inoculated 
calves developed a DTH response, mediated by effector/memory CD4+ Thl cells, at PID 60, 
further evidence of an efficient central immune response to M. paratuberculosis in this 
system. Given evidence of an adequate central immune response, but poor granuloma 
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formation at the site of infection (22) and a weak response in the draining lymph node, we 
tested the hypothesis that live M. paratuberculosis limits the immune response at the site of 
infection despite the presence of circulating M. paratuberculosis-specific effector/memory 
CD4+ T cells. To test this hypothesis, we evaluated the immune response in the lymph node 
draining the site of infection in calves previously vaccinated for paratuberculosis. We 
inoculated three calves subcutaneously in the left cervical region with the vaccine, and used 
three non-vaccinated age-matched calves as controls. At 60 days post-vaccination, each calf 
received 100 mg of live M. paratuberculosis in the right cervical region. Calves were 
euthanatized at post-vaccination day 123, and left and right superficial cervical lymph nodes, 
peripheral blood, and portions of the spleen were collected from each animal to isolate 
LNMC, PBMC, and spleen cells, respectively. 
During the course of the experiment, one vaccinated calf was euthanatized at post-
vaccination day 70 due to necrotizing myositis with failure to thrive following splaying of the 
hindlimbs. In vitro data from another vaccinated calf and a non-vaccinated calf was not 
usable due to death of cells in culture following an incubator malfunction. Therefore, for in 
vitro data for the vaccinated group, one calf was assessed, and for the non-vaccinated group, 
data was available from two calves. 
Proliferation of CD4+ T cells was compared between lymph nodes draining the site of 
vaccination and cells isolated from lymph nodes draining the challenge site. PKH67-labeled 
cells were cultured in the presence or absence of PPD for 7 days, at which time cultures were 
labeled for expression of CD4 for flow cytometric analysis. A live lymphocyte gate was 
drawn on a forward vs. side scatter plot, and CD4+ cells were further discriminated by gating 
on a CD4+ vs. PKH67 fluorescence intensity plot. Proliferation of CD4+ lymphocytes was 
107 
detected as a loss of PKH67 fluorescence, and this loss was calculated by the software as in 
experiment 1. In non-vaccinated calves, there was little antigen-specific proliferation of 
CD4+ T cells in lymph nodes draining the site of M. paratuberculosis infection (proliferation 
index for PPD-stimulated cells 1.3 ± 0.2, for unstimulated cells 1.2 + 0.2). In contrast, there 
was substantial antigen-specific proliferation of CD4+ T cells from cultures from the lymph 
node draining the site of vaccination (PPD-stimulated 2.9, unstimulated 1.2). Proliferation of 
CD4+ T cells from the site of challenge in the vaccinated animal did not substantially differ 
from proliferation in the challenge sites of non-vaccinated animals (PPD-stimulated 1.7, 
unstimulated 1.5). 
As shown in Fig 3a, M. paratuberculosis PPD-stimulated LNMC from the lymph 
node draining the site of vaccination produce substantial amounts of IFN-y, and the majority 
of IFN-y-producing cells are CD4+ (Fig 3a). Unstimulated LNMC from the same LN 
produce little IFN-y (Fig 3c). In contrast, there is little IFN-y production by CD4+ or other T 
cells from PPD-stimulated LNMC from the lymph node draining the site of subcutaneous 
challenge in the same calf at the same time point (Fig 3b). Intracellular staining for IFN-y in 
LNMC from the lymph node draining the challenge site in this calf was not significantly 
different than the staining for IFN-y from the lymph nodes draining the challenge sites in 
non-vaccinated calves (data not shown). In addition to IFN-y production by CD4+ T cells 
from the lymph node draining the vaccination site, the spleen from the vaccinated calf also 
had significant IFN-y production by CD4+ T cells (59.6% CD4+ IFN-y* T cells among total 
LNMC). 
Discussion 
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The results of the present study suggest that the local immune response to M. 
paratuberculosis infection in the draining lymph node is relatively impaired in comparison to 
the central immune response mediated by the spleen. Calves were inoculated subcutaneously 
with live M. paratuberculosis, and lymphocytes from the draining lymph node, peripheral 
blood, and the spleen were compared for their ability to proliferate and to produce IFN-y in 
response to antigenic stimulation. There was significantly greater antigen-specific 
lymphocyte proliferation and a strong trend (P=0.07) for increased antigen-specific IFN-y 
production in the spleen compared to the draining lymph node. Most M. paratuberculosis-
inoculated calves developed a positive DTH response, further suggesting a strong central 
immune response. While the vaccinated calf had significant antigen-specific proliferation 
and IFN-y production by CD4+ T cells from the lymph node draining the site of vaccination 
and a strong DTH response, there was little antigen-specific proliferation and IFN-y 
production by CD4+ T cells from the lymph node draining the site of subsequent M. 
paratuberculosis challenge in the same animal. 
Studies in humans infected with Mycobacterium tuberculosis have revealed 
compartmentalization of the immune response, with lymphocyte responses at the site of 
infection behaving differently than peripheral blood lymphocytes. There are increased 
percentages of CD4+ T cells with a memory phenotype and markedly increased amounts of 
IFN-y at the site of tuberculous pleuritis compared to the peripheral blood (2). IFN-y and IL-
2 concentrations were increased in supematants from antigen-stimulated pleural fluid cells 
compared to antigen-stimulated PBMC (1). Compared to PPD-positive controls, patients 
infected with M. tuberculosis had antigen-specific proliferative responses by bronchoalveolar 
cells which were 8-fold higher, yet antigen-specific PBMC responses which were 3-fold 
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lower, than the responses of controls (20). When stimulated with PPD, there were increased 
numbers of IFN-y-producing cells in the affected lung in tuberculosis patients compared to 
cells from the unaffected lung (20). Whether this phenomenon is a result of true immune 
compartmentalization or the selective recruitment of lymphocytes to the site of active 
infection from the peripheral blood with depletion of antigen-specific lymphocytes from the 
periphery is unknown. 
In contrast to the hyperresponsiveness of lymphocytes at the site of infection and the 
relative lack of responsiveness of PBMC in human tuberculosis, there appears to be a graded 
response among lymphocytes isolated from different immunologic compartments in ruminant 
paratuberculosis infection, with splenic lymphocytes and PBMC having the greatest response 
and lymphocytes at the site of infection being the least responsive. In cattle experimentally 
infected with Mycobacterium bovis, there is strong antigen-specific proliferation of PBMC to 
mycobacterial antigens (PPD and ESAT-6) and weaker proliferative responses by draining 
lymph node cells to these and other antigens (PPD, ESAT-6, Ag85, and hsplô.l) (19). In 
cattle clinically affected with paratuberculosis, there were graded proliferative responses to 
PPD and live M. paratuberculosis, with lymphocytes from the peripheral blood proliferating 
most strongly, followed by cells from the ileocecal lymph node, with the lowest proliferative 
responses by lamina propria lymphocytes from the ileum (15). Similarly, in sheep infected 
with M. paratuberculosis, the median antigen-specific lymphocyte proliferative responses 
were highest in peripheral blood, followed by mesenteric lymph node lymphocytes, and 
lowest in lamina propria lymphocytes (5). Data from the present experiments are consistent 
with these findings, with weaker antigen-specific responses in the lymph node draining the 
lesion site compared to the peripheral blood and spleen. 
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In delayed-type hypersensitivity testing, antigen is injected into the dermis, where it is 
captured by APCs (14). Circulating Thl effector cells recognize their specific antigen on 
these APCs, and responding T cells release cytokines which induce expression of adhesion 
molecules on vascular endothelium. Monocytes and macrophages are recruited to the site, 
and plasma and fibrin escape between the junctions in vascular endothelium, causing the 
induration. In this study, 8/11 non-vaccinated, M. paratuberculosis-inoculated calves 
developed a positive DTH response. Thus, following injection of soluble antigen from M. 
paratuberculosis, APCs successfully process and present this antigen to antigen-specific 
CD4+ T cells, demonstrating an intact systemic immune response. It is our hypothesis that 
subcutaneously inoculated M. paratuberculosis is engulfed by APCs which migrate to the 
regional lymph node, but that induction of local cellular immunity by these APCs containing 
live bacteria is impaired. If effector/memory CD4+ T cells are present at the lesion site, it is 
possible that they are not receiving proper signals for effector function due to defects in APC 
function caused by the live bacteria. It is also possible that effector/memory CD4+ T cells are 
not recruited to the lesion site, as the development of the non-encapsulated, infiltrative 
granulomatous inflammation at the site of subcutaneous infection is consistent with a poor 
CD4+ effector response (22). 
Potentially, differences in the cytokine milieu present at the sites of T cell 
development in the spleen and in the lymph node draining the site of infection could also be 
responsible for the different degrees of immune responsiveness at the different anatomic 
sites. Increased production of Th2 cytokines relative to Thl cytokines within the developing 
granulomatous inflammation could dampen the local Thl response. Dendritic cells which 
capture and successfully process antigen and migrate to the spleen or migrate to the spleen 
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prior to antigen processing may not be under the regulatory control of the localized cytokine 
microenvironment of the developing granuloma; thus, in the spleen, competent 
effector/memory CD4+ T cells are generated, which allows subcutaneously-inoculated calves 
to have a positive DTH response. Among Th2-type cytokines, TGF-(3 appears to be 
differentially regulated between the lesion site and the peripheral blood in M. 
paratuberculosis-mfected cows. TGF-p mRNA expression was increased in the ileum of M. 
paratuberculosis-infected cattle compared to uninfected controls, but stimulation of PBMC 
from M. paratuberculosis-infected cattle did not increase TGF-J3 production compared to 
controls (9). 
Few studies have evaluated the impact of mycobacterial infection on APC function in 
cattle. Although bovine DC infected in vitro with M. bovis produce IL-12 in response to 
infection, bovine macrophages infected in vitro with M. bovis produce IL-10 and little IL-12 
(12). Similar results have been obtained in murine cells infected in vitro with M. 
tuberculosis. Infected murine DC are potent producers of IL-12, whereas macrophages 
produce IL-10 and no IL-12 (11). In contrast to these studies, in vitro infection of bovine 
DCs with M. paratuberculosis results in diminished IL-12 production compared to 
lipopolysaccharide (LPS)-stimulated DCs (unpublished data). In bovine macrophages 
infected in vitro with M. paratuberculosis, there was decreased surface expression of MHC 
class II beginning at 12 hours post-infection, with a 50% reduction in MHC class II 
expression by 48 hours post-infection compared to uninfected macrophages (29). In 
addition, expression of MHC class I was reduced 24 hours post-infection (29). Compared to 
bovine DC stimulated with LPS, DC infected with M. paratuberculosis have decreased MHC 
class II expression (unpublished data). M. paratuberculosis-infected macrophages are not 
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lysed by primed autologous lymphocytes, suggesting impaired communication between the 
infected macrophage and the T cell (29). The data suggest that M. paratuberculosis actively 
interferes with APC function such that infected APCs have a decreased capacity to present 
antigen and stimulate a protective immune response. APCs containing processed soluble M. 
paratuberculosis antigen, in contrast, are not impaired in their ability to stimulate CD4+T 
cells, and are capable of stimulating a strong central immune response. 
The reason for the failure of some calves in this study to generate a DTH response 
despite strong antigen-specific lymphocyte proliferation and IFN-y production in the spleen 
is unclear. In a previous study in which DTH was assessed in subcutaneously-inoculated 
calves (22), M. paratuberculosis-infected calves had a significant increase in skin thickness 
at the site of PPD injection (3.7±0.7 mm, n=13) compared to saline-inoculated control calves 
(0.8±0.5 mm, n=6). In that study, all 13 M. paratuberculosis-moculated calves had an 
increase in skin thickness of at least 0.5 mm; none of the calves was completely negative on 
the skin test. In contrast, 3/11 non-vaccinated, M. paratuberculosis-challenged calves in the 
present study had negative DTH responses to PPD. There was no correlation between DTH 
measurements and PPD-induced proliferation and IFN-y production (data not shown). In 
fact, some calves which had no increase in skin thickness at the PPD-injection site had 
proliferation indices and IFN-y production similar to calves with the strongest DTH 
responses (data not shown). It has been shown previously that not all M. paratuberculosis-
mfected animals develop positive DTH responses. In one study, 20 of 50 DTH-negative 
cattle had histological evidence of paratuberculosis infection at post-mortem; only 10 of 
these animals had clinical signs of disease (17). The same study found that cattle can react 
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intermittently to intradermal PPD. Therefore, it is possible that evaluation of these calves at 
a later time point may have revealed a positive DTH response. 
In the present study, we used an established subcutaneous infection system to 
evaluate the immune response to M. paratuberculosis in the lymph node draining the site of 
infection, the peripheral blood, and the spleen. In subcutaneously infected animals, M. 
paratuberculosis-antigen-specific proliferation and IFN-y production were greatest in the 
spleen and were significantly greater than in the lymph node draining the site of infection. 
We then evaluated the local immune response to challenge with live bacteria in animals 
previously vaccinated for paratuberculosis. In the vaccinated calf, the lymph node draining 
the vaccine site and the spleen had marked antigen-specific proliferation and IFN-y 
production by CD4+ T cells, while the lymph node draining the challenge site in the same 
animal had little antigen-specific CD4+ T cell proliferation and no IFN-y production. The 
response in the lymph node draining the challenge site in the vaccinated animal was similar 
to the magnitude of the response of the draining lymph node in non-vaccinated animals. The 
data suggest that there is impairment of APC function at the site of infection such that 
ineffective signaling between the APC and effector/memory CD4+ T cells or reduced 
recruitment of CD4+ T cells to the lesion site results in a lack of local Thl polarization. 
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Fig 1. Antigen-stimulated spleen cells proliferate more vigorously than antigen-stimulated 
cells derived from the lymph node draining the site of infection. Proliferation of cells 
isolated from lymph nodes (LNMC), peripheral blood (PBMC), and spleen at PID 60 from 
calves inoculated subcutaneously with 100 mg (wet weight) of M. paratuberculosis. Values 
are mean±SEM; n=8. *P<0.05 compared to unstimulated cells from the same tissue. 
**P<0.05 compared to PPD-stimulated LNMC. 
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Fig 2. There is a strong trend for increased IFN-y production by antigen-stimulated spleen 
cells compared to antigen-stimulated draining lymph node cells. IFN-y production from 
cultured cells derived from lymph nodes (LNMC), peripheral blood (PBMC), and spleen at 
PID 60 from calves inoculated subcutaneously with 100 mg (wet weight) of M. 
paratuberculosis. Values are mean±SEM; n=8. *P<0.05 compared to unstimulated cells 
from the same tissue. ND, not detectable. 
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Table 1 
Lymphocyte populations in draining lymph nodes (LNMC), peripheral blood (PBMC), and 
spleens of calves (n=5) inoculated subcutaneously with M. paratuberculosis. Values listed 
are percentages ± SEM. Different letters within each row indicate significant (P<0.05) 
differences between values in different tissue compartments. 
LNMC PBMC spleen 
CD4+ 44.8 ± 3.9 A 26.1 ±3.2 B 12.7 ± 0.9 C 
CD8+ 28.8 ± 1.5 A 17.2 ± 1.5 B 30.8 ± 4.6 A 
Y ô TCR+ 7.9 ± 0.7 B 54.7 ±4.8 A 45.6 ± 2.9 A 
B cells 44.3 ± 8.2 30.3 ±2.4 26.9 ± 3.6 
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Fig 3. The CD4+ T cell response by the lymph node draining the challenge site is impaired in 
comparison to the lymph node draining the vaccination site in the same animal. Data from 
one vaccinated, M. paratuberculosis-challenged calf. At PID 123, LN cells draining the 
vaccine site (a, c) and draining the site of subcutaneous M. paratuberculosis infection (b, d) 
were harvested and cultured in the presence (a, b) or absence (c, d) of M. paratuberculosis 
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PPD for 7 days. Numbers within each quadrant indicate the percentage of lymphocytes 
within the live gate on a forward vs. side scatter plot falling within that quadrant. 
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CHAPTER 4. FAILURE OF CLASSICAL ACTIVATION OF MYCOBACTERIUM 
AVIUM SUBSP. PARATUBERCULOSIS-INFECTED MACROPHAGES BY 
ANTIGEN-STIMULATED y à T CELLS AND CD4+ T CELLS IN 
EXPERIMENTALLY SENSITIZED CATTLE. 
A paper to be submitted to Veterinary Immunology and Immunopathology. 
Frank J. Simutis, Jesse M. Hostetter, and Douglas E. Jones 
Abstract 
Paratuberculosis is a chronic, granulomatous enteritis of ruminants caused by 
infection with Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis). The 
organism resides with macrophages and has developed means of surviving and replicating 
within phagolysosomes. A previously-developed experimental system was used to study the 
ability of yb T cells to activate M. paratuberculosis-infected macrophages. Following 
surgical excision of the right superficial cervical lymph node (LN) to obtain pre-infection 
tissue, calves were inoculated subcutaneously in the left cervical region with live M. 
paratuberculosis and the draining left superficial cervical LN was removed at post-
inoculation day (PID) 60. LN cells were cultured for 7 days in the presence or absence of M. 
paratuberculosis-purified protein derivative (PPD) and sorted to obtain purified yb T cells 
and CD4+ T cells. Macrophages were obtained from peripheral blood by selecting for 
plastic-adherent monocytes and grown for 7 days. Macrophages were infected in vitro with 
live M. paratuberculosis and autologous yb T cells or CD4+ T cells were co-cultured with 
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infected macrophages for 48 hours, at which time bacterial survival as well as production of 
nitrites and interferon (IFN)-y were evaluated. Incubation of M. paratuberculosis-infected 
macrophages with autologous unstimulated yô T cells or CD4+ T cells from preinoculation 
LNs reduced intracellular bacterial viability by 33+12% and 35+12%, respectively. Cultures 
containing unstimulated yô T cells produced a small but statistically significant amount of 
IFN-y compared to cultures without added T cells. By PID 60, there was no difference in 
IFN-y production between infected cultures containing unstimulated or PPD-stimulated yô T 
cells and cultures without added T cells. Although infection of macrophage cultures caused 
increased production of nitrites at both PID 0 and PID 60, the addition of yô T cells did not 
enhance nitrite production. At PID 60, co-cultures containing PPD-stimulated CD4+ T cells 
produced significantly greater IFN-y compared to cultures without added T cells or cultures 
containing unstimulated CD4+ T cells or unstimulated or antigen-stimulated yô T cells. 
Despite the increased production of IFN-y, bacterial viability was not reduced nor was 
production of nitrites increased in co-cultures containing PPD-stimulated CD4+ T cells 
compared to cultures without added T cells. The data suggests that although yô T cells can 
reduce intracellular bacterial viability, they do not produce significant IFN-y or increase 
nitric oxide production in M. paratuberculosis-infected macrophages in vitro. In addition, 
the production of significant IFN-y by PPD-stimulated CD4+ T cells from M. 
paratuberculosis-inoculated calves is insufficient to enhance mycobacterial killing. 
1. Introduction 
Paratuberculosis (Johne's disease) is a chronic, granulomatous enteritis of wild and 
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domestic ruminants caused by infection with Mycobacterium avium subsp. paratuberculosis 
(M. paratuberculosis). M. paratuberculosis is transmitted from infected cattle to calves 
through fecal contamination within the environment; some animals apparently clear the 
infection (Chiodini et al., 1984), while in others, a long subclinical phase follows during 
which organisms can be intermittently shed in the feces (Whitlock and Buergelt, 1996). 
After 3-5 years of incubation, animals with clinical disease have progressive weight loss, 
chronic diarrhea, and decreased milk production (Whitlock and Buergelt, 1996). 
The role of interferon (IFN)-y-producing CD4+ T cells in the protective immune 
response to other mycobacteria has been firmly established. Mice deficient in MHC class II 
or depleted of CD4+ T cells by monoclonal antibodies succumb much more rapidly to 
Mycobacterium tuberculosis infection than wild-type mice, and M. tuberculosis-infected 
IFN-y knockout mice have significantly shorter survival times than their infected wild-type 
counterparts (Mogues et al., 2001). It is presumed in M. paratuberculosis infection in cattle 
that CD4+ T cells play a central role in controlling the infection, although what constitutes a 
protective response against M. paratuberculosis has yet to be defined. In calves inoculated 
via the intratonsillar route, antigen-specific CD4+ T cell proliferation was detected at 286 
days post-inoculation, with production of IFN-Y by CD4+ T cells at 313 days post-inoculation 
(Waters et al., 2003). In orally-inoculated calves, an antigen-specific CD4+ T cell response 
developed 6 months after infection (Koo et al., 2004). Despite the initial CD4+ T cell 
response, it has been well-documented that cell-mediated immunity begins to wane late in the 
disease (Chiodini, 1996). Others have shown that cattle with clinical paratuberculosis have 
decreased numbers of CD4+ T cells within the ileal lamina propria and ileocecal lymph node 
compared to control animals or those with subclinical Johne's disease (Koets et al., 2002). 
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There is decreased expression of IFN-y mRNA within the ileum and cecal lymph node in 
animals with clinical illness compared to subclinically-affected animals (Sweeney et al., 
1998). 
In contrast to what is known about CD4+ T cells, the role of yô T cells in 
mycobacterial infection is less clear. In humans and primates, yô T cells proliferate in 
response to protein (Boom et al., 1994; Born et al., 1990) and non-protein (Morita et al., 
1995; Rojas et al., 2002; Wang et al., 2003) antigens of mycobacteria in vitro. Human yô T 
cells produce IFN-y when stimulated with mycobacterial antigens (Garcia et al., 1997) and 
accumulate in mycobacterial lesions in vivo (Modlin et al., 1989). It has been suggested that 
yô T cells may provide a first line of defense before ap T cells are recruited to the lesion sites 
for antigen-specific production of IFN-y (Baldwin et al., 2002). In Mycobacterium bovis-
infected cattle, yô T cells proliferate (Rhodes et al., 2001) and produce IFN-y (Vesosky et al., 
2004) in response to stimulation with M. bovis antigens. Studies have recently focused on 
the subset of bovine yô T cells which expresses the differentiation molecule WC1, a member 
of the scavenger receptor cytosine-rich receptor family with homology to CD5 and CD6 
(Wijngaard et al., 1992). WC1+ yô T cells from M. èovw-infected cattle become activated 
following 24 hours of culture with antigen and continue to express the IL-2 receptor for at 
least 7 days in vitro (Smyth et al., 2001). WC1+ yô T cells appear to play a role in polarizing 
the developing immune response to M. bovis to a Thl-type response, as infected calves 
experimentally depleted of WC1+ cells by administration of monoclonal antibodies had 
increased antigen-specific production of IL-4, negligible IgG2 production, and decreased 
innate production of IFN-y (Kennedy et al., 2002). An understanding of the role of yô T cells 
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in paratuberculosis has come from studies using M. paratuberculosis-infected yô TCR 
knockout mice, yô T cell-deficient mice develop smaller and less numerous granulomas in 
response to intraperitoneal infection compared to wild-type mice (Tanaka et al., 2000), and 
yô T cells have been shown to exert either a negative influence (Tanaka et al., 2000) or have 
no significant effect (Stabel and Ackermann, 2002) on clearance of M. paratuberculosis in 
this experimental system. 
The hypothesis for the present study was that y ô T cells are capable of activating 
macrophages infected with M. paratuberculosis through IFN-y secretion to upregulate 
bacterial killing mechanisms. To test this hypothesis, we co-cultured infected bovine 
macrophages with autologous yô T cells derived from lymph nodes surgically excised prior 
to inoculation (post-inoculation day [PID] 0) and from lymph nodes obtained at PID 60. We 
assessed intracellular viability by bacterial culture and examined nitric oxide (NO) 
production by quantifying nitrites within the culture supernatants. IFN-y production by 
infected co-cultures was assessed using a commercial ELISA. As a positive control for 
macrophage activation, we compared the function of yô T cells to that of CD4+ T cells from 
the same lymph nodes. 
For these experiments, we used a previously-described subcutaneous infection system 
in young calves (Simutis et al., 2005). In this system, subcutaneous inoculation of live M. 
paratuberculosis into calves elicits a weak recall response in the draining lymph node by PID 
60, including weak proliferation of CD4+, CD8+, and yô T cells and little IFN-y production. 
In the study reported here, we evaluated lymphocyte function after primary restimulation 
with purified protein derivative (PPD) from M. paratuberculosis followed by a secondary 
restimulation by M. paratuberculosis-infected macrophages. Primary restimulation was 
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performed to expand M. paratuberculosis antigen-specific lymphocytes within the draining 
lymph node cell population, and from these expanded lymphocyte populations, we positively 
selected for yô T cells and CD4+ T cells, which would be include a population of activated, 
antigen-specific effector/memory cells. Upon secondary restimulation, the expanded, 
antigen-specific T cells would potentially be capable of expressing full effector function. 
2. Materials and Methods 
2.1. Monoclonal antibodies and antigens. 
To identify T cell subsets, mouse anti-bovine yô TCR (GB21A) and mouse anti-
bovine CD4 (IL-A11) were purchased from VMRD, Pullman, WA. Phycoerythrin-
conjugated rat anti-mouse IgG (BD Pharmingen, San Diego, CA) was used as a secondary 
antibody. PPD from M. paratuberculosis strain 19698 (Steadham et al., 2002) was a 
generous gift of Dr. Charles Thoen, Department of Veterinary Microbiology and Preventive 
Medicine, Iowa State University, Ames, IA. 
2.2. Animals. 
All animal protocols were approved by the Iowa State University Committee on 
Animal Care. Eight male Holstein calves were purchased from the Iowa State University 
dairy research farm (Ankeny, IA). This herd has had no clinical cases of paratuberculosis in 
the last five years, and fecal culture and antibody ELISA results from cows with chronic 
diarrhea have consistently been negative for M. paratuberculosis infection. At three weeks 
of age, calves were transported to BL2 housing for a one-week period of acclimation prior to 
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use in experiments. Calves were housed in individual concrete rooms, fed milk replacer until 
eight weeks of age, and provided a complete grain mixture and water ad libitum. 
2.3. Bacteria. 
M. paratuberculosis strain 19698 was cultured in Middlebrook 7H9 broth 
supplemented with mycobactin J. Bacteria were maintained in log phase growth by weekly 
passage; cultures 4 weeks of age were used in these experiments. Aliquots for inoculation 
into calves containing 100 mg (wet weight) of M. paratuberculosis were frozen at -80° C 
until use, thawed, and resuspended by gentle sonication prior to inoculation. Previously, an 
aliquot of this frozen inoculum was thawed and plated in 10-fold dilutions onto 7H10 agar 
plates; 100 mg wet weight of M. paratuberculosis contained approximately 5 x 10* colony-
forming units (CPU) (Simutis et al., 2005). For in vitro experiments, bacteria were washed 
in sterile saline, and the concentration of bacteria was estimated by measuring the absorbance 
at 540 nm and comparing the absorbance against a standard curve as previously described 
(Chiodini and Buergelt, 1993). Bacteria were non-immune serum opsonized by resuspension 
in autologous pre-inoculation calf serum and incubated for 1 hour at 37° C. Bacteria were 
centrifuged and resuspended at a concentration of 107 CFU/mL in RPMI 1640 medium 
containing 10% fetal bovine serum, 0.5 mM 2-mercaptoethanol, and 2 mM L-glutamine. 
2.4. Experimental design. 
At four weeks of age, the right superficial cervical lymph node (LN) was surgically 
excised from each calf following a previously-described procedure (Cheville et al., 1992) and 
transported to the laboratory in cold RPMI 1640 medium supplemented with 10% fetal 
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bovine serum, penicillin G (100 U/mL), streptomycin (100 ^g/mL), amphotericin B (250 
ng/mL), 0.5 mM 2-mercaptoethanol, and 2 mM L-glutamine (complete medium). 
Immediately after excision of the right superficial cervical LN, each calf was inoculated 
subcutaneously in the left cervical region with 5 x 10* CFU of live M. paratuberculosis in an 
area draining into the left superficial cervical LN. At post-inoculation day (PID) 60, calves 
were euthanatized with an overdose of barbiturate, and the left superficial cervical LN was 
aseptically removed and transported to the laboratory in cold complete medium. 
2.5 Isolation of peripheral blood mononuclear cells (PBMC), monocytes, and macrophages, 
and in vitro infection with M. paratuberculosis. 
PBMC were isolated by hypotonic lysis of venous blood and plated overnight in 75 
cm2 tissue culture flasks in complete medium to allow plastic adherence of monocytes. 
Nonadherent cells were washed from the flasks with warm PBS. Cultures were incubated for 
7 days in complete medium to allow differentiation into macrophages. Macrophages were 
infected with opsonized M. paratuberculosis at a ratio of 10 bacilli per macrophage. After 4 
hours, macrophages were washed three times in warmed RPMI medium without antibiotics, 
scraped from the flasks with a rubber cell scraper, and counted. Macrophages were plated in 
96-well flat-bottomed tissue culture plates at 1 x 10s macrophages per well. Uninfected 
macrophage cultures were plated in parallel. 
2.6. Expansion ofT cells by M. paratuberculosis antigens. 
To obtain a single-cell suspension of LN cells, superficial cervical LNs were thinly 
sectioned in a sterile plate, finely minced with a sterile scalpel blade, and washed from the 
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plate with fresh complete medium through a 70-/<m nylon filter (Fisher Scientific, Pittsburg, 
PA). Resulting suspensions were centrifuged over Histopaque (Sigma, St. Louis, MO) to 
separate mononuclear cells from cell debris. Mononuclear cells were washed in PBS, 
counted using trypan blue, and resuspended in complete medium at a concentration of 1 x 107 
cells/mL. One hundred microliters of this suspension (1 x 10* cells) was plated per well in 
96-well round-bottomed plates. Unstimulated cells were cultured with an additional 100 pL 
of complete medium. Antigen-stimulated cultures received an additional 100 |xL of complete 
medium containing 20 pig/mL PPD (final concentration, 10 (xg/mL). After 7 days, cultures 
were harvested and sorted to obtain purified yô T cells and CD4+ T cells. 
2.7. Purification of yôT cell and CD4+ T cell populations. 
Unstimulated and PPD-stimulated LN cells were sorted by positive selection to obtain 
yô T cells and CD4+ T cells after 7 days of culture. Wells from each treatment were pooled 
and resulting cells (2 x 107) were washed in PBS. Cells were labeled with either anti-yô TCR 
or anti-CD4 and rat anti-mouse microbeads (Miltenyi Biotec, Auburn, CA) and sorted with 
an AutoMACS cell sorter (Miltenyi Biotec). Following labeling with microbeads, cells were 
stained with phycoerythrin-conjugated rat anti-mouse secondary antibody. After positive 
selection, sort purity was checked with a FACScan flow cytometer (Becton-Dickinson, San 
Jose, CA). For most samples, one cycle of purification was sufficient to obtain >95% pure 
yô T cells or CD4+ T cells. When purity was less than 95%, a second cycle of purification 
was performed. T cells were resuspended in complete medium at a concentration of 5 x 
106/mL and rested for 4 hours prior to use in assays. Rested autologous T cells were added to 
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macrophage cultures at a ratio of 5 T cells to 1 macrophage. All assays were performed in 
duplicate. 
2.8. Measurement of nitrites and IFN-y. 
Macrophage:? cell co-cultures were incubated at 37° C and 5% C02. After 48 hours, 
plates were centrifuged and the supematants removed. Nitrites were measured in culture 
supematants using the Griess reaction. The limit of detection was 0.78 piM of nitrites. IFN-y 
was measured using a commercial ELISA for bovine IFN-y (BOVIGAM, Biocor Animal 
Health, Omaha, NE). A standard curve was constructed using recombinant bovine IFN-y 
(Serotec, Raleigh, NC). The limit of detection for this ELISA was 78 pg/mL. 
2.9. Bacterial killing assay. 
After removal of the culture supematants, macrophage:T cell co-cultures were lysed 
with 0.1% deoxycholate for 2 minutes to release intracellular bacteria. Resulting bacterial 
suspensions were suspended in sterile saline. Ten-fold dilutions of bacterial suspensions 
were plated onto Middlebrook 7H10 agar, and colonies were counted after 4 weeks of 
incubation. To calculate percent survival in cultures containing added T cells, the number of 
CFU recovered from cultures containing T cells was divided by the number of CFU 
recovered from macrophage cultures without added T cells. 
2.10. Statistical analysis. 
Data for nitrite and IFN-y production and for bacterial survival were compared 
between macrophage cultures with added T cells and macrophage cultures without T cells 
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and between cultures containing PPD-stimulated T cells and those containing unstimulated T 
cells. If data was not normally distributed, log transformation was performed to normalize 
the distribution. One-way analysis of variance was performed on log transformed data and 
means compared with Student's f-test. If log transformation failed to normalize the 
distribution, groups were compared with a Wilcoxon/Kruskal-Wallis rank sums test. 
Significance was set at P<0.05. 
3. Results 
3.1. IFN-y production 
The ability of M. paratuberculosis-infected macrophages to stimulate IFN-y 
production by yô T cells and CD4+ T cells was determined in co-culture assays containing 
infected macrophages and T cells at PID 0 and at PID 60. Because of the low recovery of 
LN cells from preinoculation (PID 0) LN, only unstimulated T cell subsets were tested. LN 
cells from preinoculation LN produced a small amount of IFN-y when co-cultured with 
infected macrophages (Fig. IA). yô T cells produced 8.5±4.0 ng/mL of IFN-y and CD4+ T 
cells produced 4.8±1.5 ng/mL of IFN-y compared to 1.4+0.8 ng/mL produced by cultures 
containing infected macrophages alone. The difference between cultures containing added 
yô T cells and macrophage cultures alone was statistically significant (P<0.05). At PID 60, 
macrophages were co-cultured with autologous PPD-stimulated or unstimulated yô T cells, or 
with PPD-stimulated or unstimulated CD4+ T cells. As shown in Fig. IB, there were no 
differences in IFN-y production between infected cultures containing unstimulated (8.6±2.9 
ng/mL) or PPD-stimulated (10.1±5.9 ng/mL) yô T cells and macrophages without added T 
cells (6.1 ±3.8 ng/mL). PPD-stimulated CD4+ T cells at PID 60 produced substantial IFN-y 
(61.2±28.5 ng/mL) when cultured with M. paratuberculosis-infected macrophages (P<0.05 
compared to infected macrophages without added T cells). In contrast, unstimulated CD4+ T 
cells from PID 60 cultured with M. paratuberculosis-mîtcteà macrophages produced similar 
amounts of IFN-y (ll.4+2.4 ng/mL) as infected macrophages without added T cells. 
Uninfected macrophage cultures with and without added T cells produced low to 
undetectable levels of IFN-y. 
3.2. Nitrite production 
To assess macrophage activation by yô T cells and CD4+ T cells, NO production was 
assessed by measuring nitrites in culture supematants with the Griess reaction. Control 
experiments determined that addition of recombinant porcine IFN-y at 10 ng/mL with 1 
Hg/mL lipopolysaccharide (LPS) to uninfected macrophage cultures resulted in increases in 
nitrite production (up to 8.5 nM) as well as morphologic changes consistent with macrophage 
activation (data not shown). As shown in Fig. 2, infected macrophages at both PID 0 and 
PID 60 produced increased amounts of nitrites when infected with M. paratuberculosis 
compared to uninfected macrophages (for PID 60, P<0.05). Infected macrophage cultures at 
PID 60 (Fig 2B) produced greater amounts of nitrites than infected macrophage cultures at 
PID 0 (Fig 2A). Addition of T cells, either PPD-stimulated or unstimulated and either yô T 
cells or CD4+ T cells, did not cause further increases in nitrite production compared to 
infected macrophage cultures without added T cells. Uninfected macrophage cultures with 
and without added T cells produced undetectable levels of nitrites. Note that despite 
substantial IFN-y production by co-cultures containing PPD-stimulated CD4+ T cells (Fig. 
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IB), nitrites were not increased in these cultures compared to other culture conditions (Fig 
2B). 
3.3. Bacterial viability 
To assess bacterial killing, cultures were lysed with 0.1% deoxycholate and the 
resulting bacterial suspensions were plated on 7H10 agar to determine CFU recovered. To 
estimate reduction in viability by the addition of T cell subsets, percent survival (percent of 
control) was calculated as the number of CFU recovered from M. paratuberculosis-infected 
macrophage cultures with the addition of T cells divided by CFU recovered from infected 
macrophages alone. Addition of unstimulated yô T cells or unstimulated CD4+ T cells from 
PID 0 reduced bacterial viability to 67±12% and 65+12% of control cultures, respectively 
(Fig 3A). Similarly, PPD-stimulated and unstimulated yb T cells from M. paratuberculosis-
infected calves at PID 60 reduced bacterial viability to 56±5% and 77±7%, respectively, of 
control cultures (Fig 3B). Similar reductions were observed for cultures containing PPD-
stimulated or unstimulated CD4+ T cells. 
To test whether IFN-y concentration or nitrite production correlated with reduction in 
bacterial viability in vitro, we performed regression analysis on IFN-y and nitrite production 
and CFU recovered. Fig. 4A presents this analysis of IFN-y production vs. CFU recovered; 
IFN-y concentration correlated poorly with CFU recovered (^=0.0171). Similarly, nitrite 
production and bacteria recovered appeared to act independently (^=0.2285, Fig 4B). 
4. Discussion 
The data from the present study indicate that allogeneic T cells added to cultures of 
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bovine macrophages infected with M. paratuberculosis can reduce intracellular bacterial 
viability by approximately 23-43%. Compared to infected macrophage cultures without 
added T cells, infected cultures containing added autologous yô T cells do not produce 
increased amounts of IFN-y or cause elevations in nitrites. In this experimental system, co-
culture of infected macrophages with allogeneic CD4+ T cells producing large amounts of 
IFN-y does not promote additional killing of intracellular M. paratuberculosis. Infection of 
macrophages with M. paratuberculosis resulted in increased production of nitrites compared 
to uninfected macrophages, but the substantial amount of IFN-y produced by purified, PPD-
stimulated CD4+ T cells co-cultured with M. paratuberculosis-infected macrophages failed to 
further elicit elevations in nitrite production compared to co-cultures without added T cells. 
At PID 0, unstimulated yb T cells produce a small but statistically significant amount 
of IFN-y when co-cultured with M. paratuberculosis-infected macrophages compared to 
infected macrophages without added T cells, yô T cells have been shown in numerous 
studies to produce IFN-y in response to mycobacterial antigens (Follows et al., 1992; Garcia 
et al., 1997; Vesosky et al., 2004), although IFN-y production by yb T cells during 
paratuberculosis infection has been called into question by others (Bassey and Collins, 1997). 
Interestingly, by PID 60, there were no differences in IFN-y production between infected 
cultures containing unstimulated or PPD-stimulated yb T cells and infected cultures without 
added T cells. Although the amount of IFN-y produced by cultures containing yb T cells did 
not change between PID 0 and PID 60, the amount of IFN-y produced by infected cultures 
without added T cells increased at PID 60. It has been shown that rat alveolar macrophages 
derived from neonates produce less IL-10 and inducible nitric oxide synthase (iNOS) than 
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alveolar macrophages derived from adult rats in response to lipopolysaccharide stimulation 
(Lee et al., 2001). In addition, production of arachidonic acid metabolites by stimulated 
bovine alveolar macrophages is decreased in young calves compared to adult cattle (Lu et al., 
1996). Thus, the relative functional immaturity of the macrophages obtained at PID 0 
compared to those at PID 60 may be the cause of the differences in IFN-y production 
between cultures with added yô T cells and those without at PID 0. The difference in nitric 
oxide production between PID 0 and PID 60 is further evidence of functional macrophage 
immaturity at PID 0; nitrite production by infected macrophage cultures was increased in all 
culture conditions at PID 60 compared to infected cultures at PID 0. 
Other investigators have demonstrated that the commercial paratuberculosis vaccine, 
which induces strong antigen-specific IFN-y production by draining lymph node CD4+ T 
cells (Simutis et al., 2005), does not cause a decrease in the number of bacteria recovered 
from infected tissues in comparison to non-vaccinated animals (Uzonna et al., 2003). CD4+T 
cells and IFN-y have been shown to be essential in clearance of M. tuberculosis, as mice 
deficient in MHC class II molecules or experimentally depleted of CD4+ T cells by 
monoclonal antibodies or mice lacking the IFN-y gene rapidly succumb to aerosol infection 
(Mogues et al., 2001). Despite the apparent importance of IFN-y in controlling 
mycobacterial infection, addition of IFN-y to M. paratuberculosis-infected macrophage 
cultures does not cause significant increases in bacterial killing (Weiss et al., 2002; Zhao et 
al., 1997; Zurbrick et al., 1988). M. paratuberculosis antigen-specific production of IFN-y is 
elevated in animals with the subclinical form of the disease (Stabel, 1996), yet these animals 
will ultimately progress to clinical disease with uncontrolled infection. The IFN-y-secretion 
pathway by antigen-specific CD4+ T cells may be intact in infected animals, at least through 
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the subclinical phase of infection. As macrophages appear unresponsive to exogenous IFN-y 
in vitro, the failure of bacterial killing may lie in a defect in macrophage function. 
M. paratuberculosis-'mfected macrophages produced increased amounts of nitrites 
compared to uninfected macrophages, but the presence of autologous T cells, both 
unstimulated or PPD-stimulated or from pre- or post-inoculation, did not significantly 
increase nitrite production. Nitrites produced by infected macrophages were extremely low 
and were consistent with the results of other investigators using bovine cells (Zhao et al., 
1997). In the study reported here, increased production of nitrites was used as a marker of 
macrophage activation, as preliminary experiments with uninfected bovine cells exposed to 
IFN-y and LPS resulted in significant increases in nitrites compared to uninfected cultures. 
NO may not play a role in killing of M. paratuberculosis in vivo, as it has been estimated that 
the amount of nitric oxide required to kill M. paratuberculosis in vitro (approximately 270 
mM) is not physiologically attainable (Zhao et al., 1997). 
Activation of macrophages by Thl-polarized CD4+ T cells leads to enhanced 
phagocytic and bactericidal activity, increased production of macrophage-derived cytokines 
(such as TNF-a and IL-1), and the production of antimicrobial substances (such as oxygen 
radicals, NO, and lysosomal enzymes) (Janeway et al., 2001). Despite their propensity 
towards a Thl-type response (Yin et al., 2000), few studies have been published evaluating 
the role of yô T cells in macrophage activation, and no published reports exist documenting 
macrophage activation by yô T cells during mycobacterial disease. A few studies in other 
experimental systems have suggested that yô T cells are capable of upregulating effector 
molecules of macrophage activation, yô T cells have been shown to upregulate macrophage 
TNF-a production in response to stimulation with LPS (Nishimura et al., 1995). 
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Macrophages from yô TCR knockout mice were found to produce small amounts of TNF-a 
in response to incubation with LPS, and preincubation of macrophages from yô TCR 
knockout mice with yb T cells from heterozygous littermates resulted in markedly increased 
TNF-a production in response to LPS stimulation. Another study demonstrated enhanced 
macrophage NO production in the presence of yb T cells in mucosal infection with Candida 
albicans (Jones-Carson et al., 1995). Depletion of yb T cells resulted in decreased mucosal 
iNOS expression and increased susceptibility to mucosal candidiasis. Under the culture 
conditions in our experiments, bovine yb T cells can reduce intracellular bacterial viability by 
23-43%, but do not appear to be involved in classical activation through IFN-y production. 
In the present study, we used a subcutaneous infection system to obtain antigen-
specific effector yb T cells and CD4+ T cells from the draining lymph node. We co-cultured 
purified T cell subsets with autologous M. paratuberculosis-infected macrophages to 
determine if yb T cells were capable of classical macrophage activation through IFN-y 
secretion. We tested unstimulated T cells as well as T cells receiving a primary stimulation 
with PPD and secondary restimulation upon exposure to M. paratuberculosis-iniected 
macrophages. Cultures containing unstimulated or PPD-stimulated yb T cells produced 
similar amounts of IFN-y as infected macrophage cultures without added T cells. Although 
CD4+ T cells do not produce significant IFN-y during primary restimulation in this 
experimental system (Simutis et al., 2005), upon secondary restimulation with M. 
paratuberculosis-mïecteà macrophages, CD4+ T cells produced substantial amounts of IFN-
y. Increased production of IFN-y by antigen-stimulated CD4+ T cells did not correlate with 
enhanced bacterial killing. These experiments indicate that bovine yb T cells do not produce 
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significant amounts of IFN-y when exposed to M. paratuberculosis-mîecXeé macrophages, 
and suggest that yô T cells may not be involved in classical macrophage activation during 
paratuberculosis infection. The data also suggest that although IFN-y secretion by antigen-
primed effector CD4+ T cells can be induced by M. paratuberculosis-infected macrophages 
in vitro, interactions between these CD4+ T cells and infected macrophages do not result in 
enhanced bactericidal activity. 
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Fig. 1. PPD-stimulated CD4+ T cells from infected animals produce significant IFN-y in 
response to macrophages infected with M. paratuberculosis. IFN-y was measured in culture 
supematants with a commercial ELIS A for bovine IFN-y. Bars represent the mean±SEM 
from 8 animals. (A) Blood-derived macrophages and lymph node derived T cells from 
preinoculation (PID 0). Infected co-cultures with added yô T cells produce increased 
amounts of IFN-y compared to infected macrophage cultures without added T cells. Co-
cultures containing uninfected macrophages do not produce detectable IFN-y. * P<0.05 
compared to infected macrophage cultures without added T cells. Mptb, M. 
paratuberculosis. ND, not detectable, gd, yô. (B) Blood-derived macrophages and T cells 
from lymph nodes draining sites of M. paratuberculosis inoculation (PID 60). Co-cultures of 
infected macrophages with PPD-stimulated CD4+ T cells produce significantly greater 
amounts of IFN-y (P<0.05) compared to infected cultures without added T cells. Co-cultures 
containing uninfected macrophages produce little IFN-y. PPD, purified protein derivative. 
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Fig. 2. M. paratuberculosis induces nitrite production by infected macrophages, but addition 
of autologous T cells does not cause further increases in nitrites. Nitrites were measured in 
culture supematants using the Griess reaction. Bars represent the mean±SEM from 8 
animals. (A) Co-cultures containing sorted preinoculation T cells. Infected macrophages, 
alone or co-cultured with autologous yô T cells or CD4+ T cells, produce similar levels of 
nitrites. Cultures containing uninfected macrophages produce low to undetectable levels of 
nitrites. Mptb, M. paratuberculosis. ND, not detectable, gd, yô. (B) Blood-derived 
macrophages and sorted T cells from lymph nodes draining sites of M. paratuberculosis 
inoculation at PID 60. Infected macrophages, cultured with or without autologous 
unstimulated or PPD-stimulated yô T cells or CD4+ T cells, produce similar levels of nitrites. 
Note that nitrites in cultures containing PPD-stimulated CD4+ T cells are not increased 
compared to cultures without added T cells, despite the substantial IFN-y produced by CD4+ 
T cell-containing cultures (Fig. IB). Cultures containing uninfected macrophages produce 
low to undetectable amounts of nitrites. PPD, purified protein derivative. 
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Fig. 3. Efficiency of bacterial killing is similar among macrophage cultures incubated with 
yô T cells and CD4+ T cells. Infected macrophage cultures described in Fig 1 were lysed 
with 0.1% deoxycholate and dilutions of bacterial suspensions were plated onto 7H10 agar. 
Bacterial survival was determined as the number of bacteria recovered from cultures 
containing T cells divided by the number of bacteria recovered from cultures without added 
T cells and is expressed as the percent of bacteria surviving (percent of control). Bars 
represent the mean±SEM from 8 animals. (A) Blood-derived infected macrophages and 
preinoculation lymph node T cells. The survival of bacteria from macrophage cultures 
containing either unstimulated yô T cells or unstimulated CD4+ T cells is similar, gd, yô. (B) 
Blood-derived infected macrophages and T cells from lymph nodes draining sites of M. 
paratuberculosis inoculation at PID 60. Despite significant production of IFN-y by 
autologous PPD-stimulated CD4+ T cells (Fig IB), killing is not increased compared to other 
culture conditions. PPD, purified protein derivative. 
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Fig. 4. IFN-y concentration and nitrite production do not correlate with bacterial killing. 
IFN-y concentration (A) and nitrite production (B) are plotted against CFU recovered from 
lysed macrophage cultures with and without added autologous T cells at PID 60. 
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CHAPTER 5: GENERAL CONCLUSIONS 
Subcutaneous inoculation of Mycobacterium avium subsp. paratuberculosis into calves 
elicits local granulomatous dermatitis and panniculitis and a proliferative T cell 
response in the draining lymph node. 
In chapter 2, we sought to develop an experimental system in the cow to reproduce 
the granulomatous inflammation and the lymphocyte response to infection with 
Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis). To accomplish this, 
we inoculated 48 Holstein calves subcutaneously in the cervical region with either live M. 
paratuberculosis, sterile saline, or a commercial vaccine for paratuberculosis. At various 
time points post-inoculation, the skin at the site of inoculation and the draining superficial 
cervical lymph node were surgically excised. The inoculation sites were assessed for the 
development of granulomatous inflammation by routine histopathology. Draining lymph 
nodes were processed to obtain live lymph node cells to assess antigen-specific lymphocyte 
proliferation and interferon (IFN)-y production. 
In response to subcutaneous inoculation with M. paratuberculosis, calves developed a 
small focal area of granulomatous and lymphocytic inflammation within the deep dermis and 
subcutis. At the earliest time point evaluated, post-inoculation day (PID) 7, inoculation sites 
contained an infiltrate of large numbers of macrophages, lymphocytes, neutrophils, and 
occasional multinucleated giant cells. A few acid-fast bacilli were present within 
macrophages. During later time points, the lesions became organized and were composed of 
central clusters of epithelioid macrophages surrounded by and intermixed with dense sheets 
of lymphocytes. By PID 60, acid-fast bacilli were rare and were no longer present in some 
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calves based upon acid-fast staining. The inflammation was non-encapsulated and infiltrated 
into the adjacent tissue. In contrast to M. paratuberculosis-inoculated calves, vaccine-
inoculated calves developed large subcutaneous granulomas at the site of vaccine 
administration. There was marked expansion of the deep dermis and subcutis with 
coalescing granulomas composed of central areas of necrosis surrounded by sheets of 
lymphocytes, plasma cells, macrophages, and neutrophils, which were, in turn, surrounded 
by dense fibrous connective tissue. 
Draining lymph node cells stimulated with purified protein derivative (PPD) were 
compared to unstimulated draining lymph node cells to determine antigen-specific 
lymphocyte proliferation and IFN-y production. Cells were labeled for surface markers and 
for intracellular IFN-y for flow cytometry. Compared to saline-inoculated calves, M. 
paratuberculosis-inoculated calves had significantly increased antigen-specific proliferation 
of total lymph node cells, with trends for increased CD4+, CD8+, and yô T cell proliferation. 
There was no significant difference in antigen-specific IFN-y production between these two 
groups of calves. The draining lymph node in vaccine-inoculated calves, in contrast, had 
marked antigen-specific proliferation and IFN-y production by CD4+ T cells. 
The data suggest that subcutaneous inoculation of live M. paratuberculosis into 
calves elicits granulomatous inflammation similar to that described for early lesions in the 
tips of intestinal villi and mesenteric lymph nodes of infected cattle. This type of 
inflammation is not protective, however, as these lesions continue to expand as the infection 
progresses. Lymphocytes trafficking to the inoculation site from the draining lymph node are 
not strongly Thl polarized, with weak CD4+ T cell proliferation and little IFN-y production. 
These findings suggest an ineffectual immune response at the site of inoculation, which may 
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be similar to the response in the intestine in paratuberculosis infection in vivo. Interestingly, 
calves inoculated subcutaneously with M. paratuberculosis developed a delayed-type 
hypersensitivity (DTH) response to M. paratuberculosis PPD, suggesting a strong central 
immune response. 
Live M. paratuberculosis impairs the development of a Thl response at the site of 
challenge despite strong central immunity. 
In chapter 3, we compared the immune response from the lymph node draining the 
site of M. paratuberculosis inoculation with the systemic immune response. As 
demonstrated in chapter 2, subcutaneous inoculation of M. paratuberculosis into calves 
results in antigen-specific proliferation of cultured lymphocytes from the draining lymph 
node with little IFN-y production, yet these same animals have a DTH response, which 
suggests the presence of circulating M. paratuberculosis-specific effector/memory cells 
which can be strongly Thl polarized. The results indicate that these calves develop weak 
local immune responses to M. paratuberculosis but strong central immunity. In the first 
experiment, we inoculated eight Holstein calves with live M. paratuberculosis in the cervical 
region as in chapter 2. At PID 60, the lymph node draining the site of infection, peripheral 
blood, and a portion of the spleen were collected to isolate lymphocytes for functional 
analysis. 
We demonstrated that there are different degrees of immune responsiveness within 
the different tissue compartments following subcutaneous M. paratuberculosis infection. 
Lymphocytes derived from draining lymph nodes, peripheral blood, and the spleen were 
cultured in the presence or absence of PPD for 7 days, at which time antigen-specific 
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proliferation and IFN-y production were assessed. Although there was antigen-specific 
lymphocyte proliferation and IFN-y production in all three compartments, there was 
increased PPD-induced lymphocyte proliferation (P<0.05) and a trend for increased IFN-y 
production (P=0.07) in the spleen relative to the draining lymph node, with an intermediate 
response by peripheral blood cells. This experiment suggests that at the site of infection, 
reduced CD4+ T cell trafficking into the lesion or impaired antigen-presenting cell (APC) 
function induced by infection with live M. paratuberculosis may prevent the development of 
a strong local Thl response. Possible APC defects include ineffective antigen presentation, 
impaired costimulation, or reduced migration by M. paratuberculosis-infected APCs. The 
local cytokine milieu at the site of developing granulomatous inflammation may also have an 
influence on the developing Thl response, with a relative increase in Th2 cytokines, such as 
IL-10 released from infected macrophages or TGF-|3, dampening the development of a strong 
Thl response. APC functional defects may not be present at sites distant from the 
microenvironment of the granuloma, allowing central development of a Thl response. 
In the second experiment, we further examined the disparity between the local 
immune response and the systemic immune response by challenging calves having a strong 
local and central Thl response induced by vaccination. As shown in chapter 2, vaccination 
with the killed bacterin in oil adjuvant induces marked antigen-specific proliferation and 
IFN-y production by draining lymph node CD4+ T cells during the recall response. For this 
experiment, we vaccinated three calves in the left cervical region, and used three non-
vaccinated calves as controls. Sixty days after vaccination, all calves were challenged with 
live M. paratuberculosis in the right cervical region. At PID 123, all calves were 
euthanatized, and the lymph node draining the vaccine site (or the non-vaccinated site in non-
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vaccinated animals) and the lymph node draining the challenge site as well as peripheral 
blood and the spleen were collected for analysis of CD4+ T cell proliferation and IFN-y 
production. In vitro data was available from one vaccinated calf and two non-vaccinated 
calves. 
The lymph node draining the site of vaccination as well as the spleen in the 
vaccinated calf had substantial production of IFN-y by CD4+ T cells in PPD-stimulated, but 
not in unstimulated, cultures. In contrast, the lymph node draining the M. paratuberculosis 
challenge site in the vaccinated animal had few CD4+ IFN-y* cells, and the results from the 
lymph node draining the challenge site in the vaccinated calf were similar to those from the 
lymph nodes draining the challenge sites in non-vaccinated calves. The results provide 
further strength to the argument that infection with live M. paratuberculosis induces defects 
in APC function, with the resulting failure to promote a strong local Thl response, which 
could include ineffective APC:T cell signaling or reduced regulation of trafficking of effector 
CD4+ T cells into the lesion site. 
Calves were tested for DTH responses to confirm strong systemic immune responses 
to M. paratuberculosis, and 8/11 non-vaccinated, M. paratuberculosis-challenged calves as 
well as the vaccinated calves developed positive DTH responses. This suggests that at the 
site of soluble M. paratuberculosis antigen deposition in the dermis in M. paratuberculosis-
infected calves, APCs phagocytose and process antigen for presentation to CD4+ T cells on 
major histocompatability (MHC) class II molecules. Antigen-specific effector/memory CD4+ 
T cells recognize this antigen:MHC complex and release cytokines which ultimately recruit 
monocytes and macrophages and allow an influx of serum and fibrin to the site of antigen 
deposition. This positive DTH response indicates the presence of CD4+ effector/memory T 
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cells specific for M. paratuberculosis in calves inoculated subcutaneously with M. 
paratuberculosis. Despite this systemic Thl response, however, a protective response is not 
generated at the challenge site. Challenge with live M. paratuberculosis results in a weak 
recall response from the draining lymph node, with little antigen-specific CD4+ T cell 
proliferation and IFN-y production. As inhibition of the Thl response is observed when live 
bacteria are injected and not following administration of soluble antigen, the data suggest that 
live M. paratuberculosis has developed mechanisms for inhibiting the development of 
protective immunity at the site of infection, either through failure of recruitment of 
effector/memory CD4+ T cells to the lesion site or through defects in APC function or 
migration at the site of infection. 
Antigen-stimulated yô T cells and CD4+ T cells from the lymph node draining the site of 
infection do not classically activate M. paratuberculosis-infected macrophages. 
In chapter four, we used the experimental subcutaneous inoculation system to 
generate a population of yô T cells to determine if yô T cells are capable of activating M. 
paratuberculosis-infected macrophages. For these experiments, we used eight Holstein 
calves and harvested tissues prior to and after subcutaneous inoculation with M. 
paratuberculosis. The right superficial cervical lymph node was harvested at PID 0 to obtain 
preinoculation lymph node cells. Calves were then inoculated subcutaneously in the left 
cervical region with live M. paratuberculosis, and the lymph node draining the site of 
inoculation was excised at PID 60. Peripheral blood was obtained from each calf at PID 0 
and PID 60 to obtain monocyte-derived macrophages for in vitro infection. 
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Lymph node-derived lymphocytes were cultured for 7 days in the presence or absence 
of M. paratuberculosis PPD in 96-well tissue culture plates. After 7 days in culture, 
lymphocytes were magnetically sorted to obtain purified populations of unstimulated and 
PPD-stimulated yô T cells and unstimulated and PPD-stimulated CD4+ T cells. Macrophages 
were prepared by selecting for plastic-adherent monocytes and culturing for 7 days. 
Macrophages were infected with M. paratuberculosis, and purified populations of autologous 
unstimulated or PPD-stimulated yô T cells or CD4+ T cells were added to the infected 
macrophages. Forty-eight hours after in vitro infection, culture supematants were removed 
and tested for the presence of nitrites (an indicator of nitric oxide production and macrophage 
activation) and for soluble IFN-y. Macrophage cultures were then lysed to release 
intracellular bacteria, and dilutions of bacterial suspensions were plated onto mycobacterial 
agar to determine bacterial survival. 
Addition of purified T cell subsets at PID 0 reduced intracellular bacterial viability by 
approximately 35%. Addition of unstimulated or PPD-stimulated yô T cells from sensitized 
cattle at PID 60 failed to further decrease intracellular bacterial viability. At PID 60, infected 
co-cultures containing PPD-stimulated CD4+ T cells produced significantly greater amounts 
of IFN-y compared to cultures without added T cells. Cultures containing M. 
paratuberculosis-infected macrophages produced significantly greater amounts of nitrites 
compared to uninfected cultures, but addition of yô T cells to infected cultures did not cause 
additional increases in nitrites. The significant production of IFN-y by PPD-stimulated CD4+ 
T cells also failed to further increase nitrite production by M. paratuberculosis-infected 
cultures. 
The primary objective of this experiment was to determine if bovine yô T cells are 
capable of activating M. paratuberculosis-infected macrophages to increase bactericidal 
mechanisms. In chapter 2 we demonstrated that yô T cells do not produce IFN-y during the 
recall response in experimentally-infected calves, a finding similar to others using other 
experimental systems for paratuberculosis infection. Although unstimulated yb T cells from 
preinoculation tissue produced a small but statistically significant amount of IFN-y when 
exposed to M. paratuberculosis-infected macrophages compared to infected macrophages 
without added T cells, the ability of yô T cells to affect bacterial killing was not greater than 
that of unstimulated CD4+ T cells, which did not produce significant amounts of IFN-y. By 
PID 60, there were no differences in IFN-y production between infected cultures containing 
unstimulated or PPD-stimulated yb T cells and infected cultures without added T cells. 
Although the amount of IFN-y produced by cultures containing yb T cells did not change 
between PID 0 and PID 60, the amount of IFN-y produced by infected cultures without added 
T cells increased at PID 60. At 60 days post-inoculation, there were no differences in IFN-y 
production between infected cultures without added T cells and infected cultures containing 
unstimulated or PPD-stimulated yô T cells. The relative functional immaturity of the 
macrophages obtained at PID 0 compared to those at PID 60 may be the cause of the 
differences in IFN-y production between cultures with added yb T cells and those without at 
PID 0. Thus, IFN-y production does not appear to be a function of yb T cells in M. 
paratuberculosis infection in vitro. There were no differences between unstimulated and 
PPD-stimulated yb T cells in their ability to induce mycobacterial killing, and there were no 
differences in killing between yb T cells and CD4+ T cells. The data suggests that under the 
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conditions in this experiment, yô T cells do not specifically activate M. paratuberculosis-
infected macrophages. 
In these experiments, we evaluated the ability of PPD-stimulated CD4+ T cells to 
activate macrophages, as antigen-specific CD4+ T cells have been shown to activate 
macrophages infected with intracellular pathogens in other experimental systems. Thus, we 
intended to use PPD-stimulated CD4+ T cells as a positive control for macrophage activation. 
We found, however, that despite the production of significant IFN-y by these cells, bacterial 
killing was not increased by the addition of PPD-stimulated CD4+ T cells compared to 
cultures containing other purified T cells. Thus, PPD-stimulated CD4+ T cells from lymph 
nodes draining the site of M. paratuberculosis infection are not suitable for use as a positive 
control for experiments on the activation of M. paratuberculosis-mfected macrophages. It 
has been shown by our laboratory and by others that addition of IFN-y and 
lipopolysaccharide (LPS) to uninfected bovine macrophage cultures induces macrophage 
activation, as determined by increased nitric oxide production and changes in cellular 
morphology consistent with an activated phenotype. It has also been shown, however, that 
addition of IFN-y and LPS to M. paratuberculosis-infected bovine monocytes does not affect 
bacterial killing, suggesting that stimulation of M. paratuberculosis-infected macrophages 
with IFN-y and LPS in vitro would also not make an acceptable positive control. While 
factors involved in intracellular survival of M. paratuberculosis in bovine macrophages are 
beginning to be elucidated, factors influencing bacterial killing are poorly understood. Once 
a positive control for intracellular killing of M. paratuberculosis is found, we will have a far 
greater understanding of the immunological defects which allow survival and proliferation of 
this organism within the host cell. 
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Model for interactions between M. paratuberculosis and the bovine immune system 
during the early stages of paratuberculosis 
Using data from these experiments, data from the literature on M. paratuberculosis 
and other pathogenic mycobacteria, and information from other experimental systems, a 
model for the interactions between M. paratuberculosis and the bovine immune system can 
be proposed. The neonatal calf ingests M. paratuberculosis through contaminated milk or 
colostrum, from fecal contamination of the dam's udder, or from licking fecal-contaminated 
objects in its environment. After ingesting this first infectious dose of organisms, M. 
paratuberculosis penetrates the mucosa of the ileum by passing through M cells of the dome 
epithelium, where organisms are phagocytosed by macrophages and dendritic cells. A 
percentage of the invading organisms is subsequently killed, while remaining organisms 
resist degradation by interfering with phagolysosomal maturation and acidification. 
Degraded bacteria are processed for antigen presentation on MHC class II molecules. APCs 
loaded with antigen migrate to the Peyer's patches and the draining lymph node, where they 
present antigen to antigen-specific T cells. In the lymphoid tissue, APCs induce expansion of 
antigen-specific CD4+, CD8+, and yb T cells, which are relatively defective in their ability to 
produce Thl-type cytokines. These lymphocyte populations then migrate to the site of 
infection guided by adhesion molecules on vascular endothelium; natural killer (NK) cells 
and NK T cells are also likely recruited to the site of infection and may be the predominant 
sources of IFN-y at the site of infection. In addition to APC migration to draining lymphoid 
tissues, a population of APCs containing processed M. paratuberculosis antigen migrates to 
the spleen for presentation of antigen to splenic T cells. A population of effector/memory 
CD4+ T cells is produced in the spleen, and these CD4+ T cells enter the peripheral 
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circulation. In vivo infection can be detected using lymphocyte proliferation or IFN-y 
production assays from peripheral blood cells, which would contain circulating M. 
paratuberculosis-specific CD4+ T cells derived from the spleen, and the infected animal 
would have a positive DTH response. 
In a fecal-contaminated environment containing large numbers of M. 
paratuberculosis organisms, the calf would be expected to receive multiple doses of 
organisms. Ingestion of multiple doses could result in a multifocal lesion distribution as 
organisms invade at multiple sites along the length of the distal small intestine. Because the 
infected calf develops a strong DTH response following the initial infection, effector/memory 
CD4+ T cells which can be strongly Thl polarized are present in the peripheral circulation. 
Despite strong systemic immunity, when faced with a subsequent infection the lymphoid 
tissue draining the site of infection behaves as a new focus of infection, with a lack of Thl 
polarization. Either effector/memory CD4+ T cells are not recruited to the lesion site, or 
there are defects in APC function or migration following infection with live M. 
paratuberculosis which results in the failure to provide the necessary signals to the newly 
recruited M. paratuberculosis-specific CD4+ T cells to express their effector function. 
The role of yô T cells in M. paratuberculosis infection is less certain, but these cells 
may regulate cellular traffic during the formation of the granulomatous inflammation in 
response to infection. Although yô T cells do not produce significant IFN-y when exposed to 
M. paratuberculosis-infected macrophages in vitro, infected macrophages exposed to yô T 
cells are able to kill a percentage of intracellular organisms without upregulating nitric oxide 
production. Classical macrophage activation does not appear to be induced by yô T cells. 
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M. paraîuberculosis-infected macrophages exposed to large amounts of IFN-y by 
contact with Thl-polarized effector CD4+ T cells are not classically activated to upregulate 
nitric oxide production or to enhance bactericidal activity, either due to a defect in 
macrophage function induced by M paraîuberculosis or impairment in the IFN-y signaling 
pathway within the infected macrophage. Thus, CD4+ effector/memory T cells may be 
functionally competent but unable to sufficiently activate infected macrophages, resulting in 
proliferation of intracellular bacteria. As the disease progresses, more macrophages are 
recruited to the infection site by chemokines secreted by T cells in an attempt to contain the 
infection. Live organisms continue to reside and multiply within immature phagolysosomes. 
Lesions expand by the recruitment of macrophages and influxes of T cells, and the multifocal 
infection sites eventually coalesce. Despite strong systemic cell-mediated immunity, APC 
defects within the developing inflammation prevent full expression of CD4+ T cell effector 
function locally. The combination of impaired local CD4+ T cell function and the failure of 
infected macrophages to be sterilized of bacteria allows the infection to progress without 
restraint. 
